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Background: Metabolic control declines during adolescence, increasing the risk of severe 
medical complications. Numerous burdensome treatments including insulin management, 
blood glucose monitoring, diet and exercise are necessary to prevent such complications. 
Adolescence is characterised by the transition from reliance on the family to independence 
and increased peer affiliation. It is therefore important to examine the roles of family and 
peer support for diabetes management tasks within a developmental context. Previous 
research indicates that family may have a role in supporting practical diabetes management, 
whilst peers may provide emotional support. Currently there is no research that compares 
the impact of diabetes-specific family and peer support on both metabolic control and 
quality of life. The present study addresses these issues. 
Methods: Ninety adolescents aged 13-18 with type 1 diabetes participated in this cross-
sectional study. Data included youth report of diabetes-specific social support (DSSQ) from 
peers and family, quality of life (PedsQL) and metabolic control (HbA1c). The relationships 
between social support, quality of life and HbA1c were examined using t-tests and 
correlations. Fishers Z transformations and hierarchical multiple regression were used to 
investigate the social support measures as potential predictors of HbA1c and quality of life. 
Results: Family provided significantly more support for practical diabetes management 
tasks than did peers. Peers provided significantly more support for exercise, but less 
emotional support, than did family. Better metabolic control was predicted by lower levels 
of peer support for insulin management, higher levels of peer support for blood glucose 
monitoring, increased mood and higher levels of family support for exercise. Quality of life 
was predicted by increased mood, higher levels of family emotional support, family support 
for diet, lower levels of peer support for insulin management and higher levels of peer 
support for exercise. 
 Conclusion: Whilst family support remains important throughout adolescence, peer support 
also has an important role in the metabolic control and quality of life of adolescents with 
diabetes. This has implications for clinical practice, the most significant of which being the 




1.1 General introduction 
Diabetes mellitus (type 1) is a disease primarily diagnosed within childhood or young 
adulthood that is fatal if left untreated. However, with modern advances in treatment and 
management it is now considered to be a chronic illness requiring intensive and 
continuous monitoring. As monitoring is performed almost entirely by the patient, the 
disease differs from most other chronic illnesses. Even when the condition is under strict 
control, acute difficulties such as hypoglycaemic attacks are relatively common and 
require additional support. The unrelenting nature of the management and symptoms of 
diabetes can prove to be a psychological burden for all patients. Negotiating diabetes as 
well as the developmental tasks of adolescence can be an added burden. The transition 
for young people from parental control and dependence to independence and autonomy 
is of particular importance when considering diabetes-related management tasks. 
Disruptions caused by diabetes to the psychological, social or physical development of 
adolescents may therefore have a significant impact on both physical health and quality 
of life. 
 
This introduction provides an overview of diabetes, its management and available 
treatments. The issues surrounding the support available to adolescents with diabetes, 
medical complications and quality of life for those with the condition are then discussed. 
 
The literature for this review was initially obtained through numerous search-term 
strings on the following databases: Psychlit, Psycharticles, Medline, Ovid, Cochrane 
Library and PubMed. The following search terms were used: “adolesc*, diabet*, social 
support, quality of life, metabolic control, glyc* control. Further articles were obtained 
through the exploration of citations in the original research papers. 
Introduction  
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1.2 What is diabetes? 
1.2.1 Historical context 
The term ‘diabetes’ is Greek in origin, meaning ‘passing through’ which highlights the 
two common symptoms of diabetes: polydipsia (excessive thirst) and polyuria 
(excessive urine volume). The term ‘mellitus’ also has Greek roots, meaning ‘honey or 
sweet’. The honey-sweet nature of the urine of patients with diabetes was first noticed 
by the ancient Hindus, when ants and flies would be attracted to the urine of those with 
the disease (Sanders, 2002). The first use of the term ‘diabetes’ is thought to have been 
by Aretaeus, a disciple of Hippocrates, who described the ailment as “… a wonderful 
affection, not very frequent among men, being a melting down of the flesh and limbs 
into urine…” (as cited in Owens, 1986 p.3).  
 
Until 1921, diabetes was a fatal condition. Those affected would develop severe 
dehydration followed by widespread organ failure. The work of Joseph von Mering and 
Oskar Minkowsk in 1889 began the life-saving discovery of the role of insulin in 
preventing diabetes-related deaths (Sanders, 2002). This work was more famously 
repeated and developed by Sir Frederick Gant Banting and his 22-year-old research 
assistant, Charles Herbert Best in 1921 (Sanders, 2002). For the first time, insulin was 
identified and used as a treatment for diabetes. It was not a cure, but appeared to give 
life to those with inevitable death sentences. That said, medical professionals later 
realised that there were severe complications associated with the condition including 
renal failure, loss of limb function and blindness. 
 
Since 1921, the development of modern technologies and research has led to dramatic 
changes in diabetes care. In the last 20 years, patients have moved from using glass 
syringes with primitive porcine and bovine insulins, through to continuous subcutaneous 
insulin infusion (CSII) using electronic insulin pumps and synthetic insulins with 
Introduction  
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varying response times. The medical goals have significantly changed over the last 
century, from survival to ‘normal life’. A ‘normal life’, however, implies both physical 
health and well-being: at present, this requires intensive daily management of the 
condition.  
1.2.2 Types of diabetes 
The first internationally accepted classification of diabetes was drawn up by the World 
Health Organisation and modified in 1985 to include three distinct types of diabetes:   
(a) insulin dependent diabetes mellitus (IDDM, also known as type 1), (b) non-insulin 
dependent diabetes mellitus (NIDDM, also known as type 2) and (c) gestational 
diabetes. More recent research into the aetiology of the conditions resulted in a 
modification of the classification. In 1997, the American Diabetes Association suggested 
that the terms IDDM and NIDDM be removed from diabetes classifications, the 
definitions of type 1 and type 2 be expanded, and an ‘others’ group be included to give a 
better idea of the underlying causes (Turner & Wass, 2002).  
 
Type 1 diabetes is the most common metabolic disease of the young (Struwe, 1991). It is 
an autoimmune disorder in which the destruction of pancreatic beta cells causes an 
absolute insulin deficiency and inability to produce any further insulin (Bach, 1994). 
This results in chronic hyperglycaemia (an accumulation of glucose in the blood) with 
disturbances in the metabolism of carbohydrates, protein and fat (Scottish Intercollegiate 
Guidelines Network; SIGN, 2001). There is no cure for this condition and it requires 
life-long management and treatment.  
 
While not studied here, type 2 diabetes is the most prevalent of all the conditions, 
affecting approximately 5-7% of the UK population with a peak onset age of middle to 
late adulthood (Turner & Wass, 2002). It is classified by a reduction in insulin 
production and concurrent increase in insulin resistance, although is not autoimmune in 
Introduction  
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nature. It is often associated with poor diet, being overweight and co-morbid conditions 
including arthero-sclerotic vascular disease, coronary heart disease and stroke (SIGN, 
2001). This condition can be effectively treated, with patients sometimes requiring 
reduced treatment or, occasionally, no further medical treatment when significant weight 
has been lost and a healthy diet and lifestyle maintained.  
 
Gestational diabetes occurs primarily during pregnancy and can result in poorer foetal 
health than a non-diabetic pregnancy. It is managed through a strict diet and 
occasionally through insulin treatment or tablets. Regular blood glucose monitoring is 
required. It is usually temporary and remits postpartum. 
 
Due to clinical and epidemiological distinctions between the different types of diabetes, 
it is important to treat them as distinct conditions with different management strategies 
required. This study and the following review will therefore focus only on the 
autoimmune condition of type 1 diabetes. 
1.3 Type 1 diabetes 
Pathophysiology 
Insulin is a 51 amino acid peptide hormone that is secreted into the blood and facilitates 
the entry of glucose from the blood into the body’s cells. Without insulin, this glucose 
will accumulate within the blood (hyperglycaemia) and cannot provide the body with the 
energy it requires. Cells are therefore forced to use the body’s stored energy reserves 
(Seiffge-Krenke, 2001). This is initially glycogen, and then later the body relies on fat 
and protein stores to sustain itself. The burning of fat stores for energy leads to the 
production of highly acidic ketones that accumulate in the blood (diabetic ketoacidosis 
or DKA). This places an increased demand on the kidneys to work harder to clear the 
blood of both excess glucose and ketones resulting in frequent urination, dehydration 
Introduction  
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and the loss of essential minerals including sodium. Without treatment by subcutaneous 
injection of insulin, type 1 diabetes will result in death caused by the body’s cells 
starving - despite the presence of sufficient foodstuffs. 
Prevalence 
The UK charity, Diabetes UK, states that of a (2006) population of 5.2 million in 
Scotland, approximately 197,000 had confirmed diabetes mellitus and a further 90,000 
were believed to have the disease but were as yet undiagnosed (Scottish Diabetes Survey 
Monitoring Group, 2008). The number of people with diabetes is doubling every decade 
and it has been reported that 10% of the total NHS budget (approximately £1 billion 
each year) is used to treat the disease and its complications (NHS Quality Improvement 
Scotland, 2008).  
 
This study focuses on three health board areas: Tayside, Forth Valley and Fife. The 
prevalence of diabetes in each is representative of that in Scotland as a whole (Table 1). 
 
Table 1:  
Prevalence of Diabetes within the Diabnet Health Boards 
Health Board Number of people diagnosed with each sub-
type of diabetes: 
 
 Type 1 Type 2 ‘Other’ Total Total prevalence 
within general 
population 
NHS Tayside 1,570 13,792 302 15,664 4.0% 
NHS Forth Valley 1,460 10,114 112 11,686 4.1% 
NHS Fife 1,782 12,563 227 14,572 4.1% 
SCOTLAND 26,294 166,926 3,581 196,801 3.9% 
 
There are nearly 2000 people with type 1 diabetes under the age of 16 in Scotland, with 
a 2% rise in prevalence per annum (Greene & Waugh, 2004). Therefore diabetes in 
adolescence has a potentially significant impact on NHS services, especially in the areas 
Introduction  
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of finance, staffing capacity and service development. As a result, this population 
warrants further study. 
1.3.1 Management 
Although diabetes cannot be cured, it can now be treated very successfully with 
intensive management. The aim of diabetes management is to maintain stable levels of 
blood glucose within the range of 4-10 mmol/L. To achieve this, a number of treatment 
strategies are required. These include insulin management, blood glucose monitoring, 
diet (these will be collectively referred to as practical diabetes management tasks) and 
exercise (considered to be a form of ‘companionship’ in diabetes social support research 
and will subsequently be identified as such, Bearman & La Greca, 2002). Diabetes is 
considered to be one of the diseases most heavily reliant on self-management and self-
care (Austin, 2005). The day-to-day management of the condition is undertaken almost 
entirely by the patient themselves, with additional support given from medical teams, 
and social supports that include family and peers. This support is vital to ensure that the 
patient maintains their health and is able to persevere with their life-long treatment, 24 
hours a day. The treatment strategies required in diabetes management will now be 
discussed in turn. 
Insulin management 
As individuals with diabetes are unable to produce insulin themselves it must be 
provided artificially. Currently, insulin cannot be taken orally as the stomach’s digestive 
enzymes break down the hormone before it can take effect. It must therefore be 
delivered subcutaneously, usually in the form of individual injections, but increasingly 
using a continuous subcutaneous insulin infusion device or ‘insulin pump’. Recently, an 
inhaled insulin has become available for adults and is currently under clinical trials for 




Types of insulin 
There are more than 30 types of insulin preparations available that vary in terms of onset 
of action, peak effect and duration of action. Long-acting insulins (e.g., human ultratard) 
are typically taken once (at night) or twice a day, as their effects can last up to 24 hours. 
This means that frequent injections are not required throughout the night. However, if 
used during the day, this form of insulin therapy is very restrictive for the individual as it 
cannot allow for any changes in routine. Long-acting insulins require the individual to 
eat specific types and amounts of food at the same time each day to fit with the insulin’s 
pattern of onset. This insulin also needs to be refrigerated, therefore it is more difficult 
for adolescents to take part in spontaneous social plans such as sleepovers or meals out.  
 
Short-acting insulins allow greater flexibility but must be taken 30 minutes prior to 
eating to be effective. This allows the individual to have greater choice over their menu, 
but is more likely to lead to hypoglycaemia (acute complication of diabetes due to lack 
of glucose in the blood) if meals are delayed or insufficient carbohydrate is consumed. 
The newer insulins available (e.g., lispro) can be taken at the same time as food is eaten, 
allowing much greater flexibility in terms of the choice and timing of their diet, with a 
reduced risk of hypoglycaemia. Both short-acting and the newer insulin analogues must 
be taken more frequently as they have shorter durations. This, therefore, requires the 
individual to carry the injection equipment and inject throughout the day, which can be 
intrusive to their daily routine.  
Insulin regimens 
The vast majority (94%) of young people in Scotland are required to take two or three 
injections daily (Greene & Waugh, 2004). This typically reduces the number of 
injections required whilst away from family support (e.g. at school). Each dose of 
insulin must be calculated based on current blood glucose levels, planned dietary input 
and future energy expenditure (e.g., exercise). Intensive insulin therapy (four injections 
Introduction  
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per day) is associated with significantly reduced risk of long-term complications (The 
Diabetes Control and Complications Trial research group; DCCT, 1994). However, it 
has a number of potential disadvantages: injections are required more frequently 
throughout the day, including at times when the young person is at school or away from 
family support (McMahon et al., 2005; SIGN, 2001). The SIGN guidelines identify that 
an intensive insulin therapy should be delivered as part of a comprehensive support 
package, however it is acknowledged that at present there is “no evidence on the most 
effective form of support” (SIGN, 2001 p.4). The guidelines suggest that this might 
involve patients, their families and the local multidisciplinary team; however the specific 
roles are not identified.  
Insulin pump therapy 
Insulin pump use has been shown to improve metabolic control and reduce the 
frequency of hypoglycaemic attacks, particularly for young people (Battelino, 2006; 
McMahon et al., 2005). Insulin pumps are external devices that consist of a 
programmable pump and insulin storage reservoir to which the patient is continuously 
connected through a cannula inserted under the skin. The pump delivers insulin 
continuously at a constant or variable basal rate (pre-programmed by the patient), with 
an additional dose delivered by the patient at meal times (National Institute for Health 
and Clinical Excellence; NICE, 2004). This allows a greater degree of flexibility in 
lifestyle (e.g. less rigid meal times and the ability to take part in social activities; NICE, 
2004). Insulin pumps can contain up to 6 or 7 days’ worth of insulin that does not need 
to be refrigerated. Therefore young people can be more flexible in terms of spontaneous 
social plans.  
 
Pump therapy requires regular and intensive blood glucose monitoring to prevent the 
risk of acute complications such as DKA (discussed in detail later). Individuals on pump 
therapy are at an increased risk of DKA from potential pump failure, as the individual 
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has no ‘back up’ of long-acting insulin in their blood. Therefore those who use pump 
therapy must be committed and diligent in their approach to monitoring (NICE, 2004). 
This is often challenging and requires additional reminders from family or peers. Whilst 
insulin pump technology is currently unable to automatically adjust for food 
consumption or altered blood glucose levels, insulin is delivered by the touch of a 
button, rather than a (painful) injection. This is less physically intrusive than injections 
for the adolescent. However, the task might also be more easily forgotten without 
prompts from family or peers (McMahon et al., 2005).  
Individual differences in insulin requirements 
Due to individual physiological differences such as insulin sensitivity and resistance, 
insulin requirements vary greatly between individuals. During puberty, there is a 
physiological rise in insulin resistance, which is particularly exaggerated in type 1 
diabetes (Caprio et al., 1994). Adolescence is typically a time that requires many dose 
adjustments and frequent additional monitoring to calculate the changing dose of insulin 
required. 
Summary 
Whilst long acting insulins reduce the frequency of injections needed, they are more 
rigid and restrictive in terms of routine and diet. Short-acting insulins are more flexible, 
but require more frequent administration. This has consequences for adolescents when 
with peers in social situations, when they may be more likely to forget or avoid their 
injections due to social pressures. 
 
Adolescents using pump therapy who regularly monitor their own blood glucose are able 
to identify their insulin requirements throughout the day and night, adjust their pump to 
respond to these changes and create a more individualised and flexible approach to 
treatment. Pumps allow more flexibility for social activities, but pose a greater challenge 
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with an increased need for blood glucose monitoring; pump users may require additional 
support and reminders from others. 
Blood glucose monitoring 
The constantly changing requirements for insulin within the body require close 
monitoring to maintain blood glucose levels. This is typically done using a home 
monitoring blood glucose meter. The adolescent with diabetes must use a ‘finger-prick’ 
device, which consists of a small needle inserted into the finger to produce a blood 
droplet. This blood is then placed on a testing strip inserted into the meter and the levels 
of glucose in the blood are displayed. International guidelines based on the DCCT 
(1994) suggest that all individuals with diabetes should test their blood glucose at least 
four times per day. The tests enable the person to react to changes in blood glucose level 
before they escalate into acute emergencies. However, it is widely acknowledged that 
blood glucose monitoring is often the most challenging aspect of diabetes care for young 
people (Bui et al., 2005). Barriers to daily blood glucose monitoring include the 
inconvenience of obtaining the testing materials required, finding the time and 
opportunity to test and the pain associated with the ‘finger prick’ itself. Such testing can 
also attract unwanted attention from others (Bui et al., 2005). 
 
Close monitoring of blood glucose enables insulin doses and carbohydrate intake to be 
altered to maintain a stable blood glucose level, and is particularly vital when 
adolescents with diabetes are unwell, doing extra exercise or have a change in routine. 
However, blood glucose monitoring is often the aspect of diabetes management most 
readily forgotten or ignored due to its intrusive impact on daily functioning (Thomas et 
al., 1997). Young people regularly estimate their own blood glucose based on internal 
physical sensations rather than using the specialist equipment to respond to nagging to 
test by family members. (Kyngas & Barlow, 1995; Meltzer et al., 2003) Such errors lead 
to inappropriate self-treatment such as overeating or overdosing on insulin. Whilst blood 
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glucose monitoring often requires prompting to ensure that it is completed, it is clearly 
difficult to achieve a balance between maladaptive ‘nagging’ and adaptive support. 
Summary 
Blood glucose monitoring is painful and intrusive. However, it is vital to ensure blood 
glucose stability and prevent acute and chronic complications. Achieving the 
recommended four tests per day may require prompting from others. 
Diet 
Nutritional recommendations for adolescents with type 1 diabetes are the same as for all 
healthy adolescents (Committee on Examination of the Evolving Science for Dietary 
Supplements, 2002). However there are a number of additional dietary concerns that 
must be taken into account with type 1 diabetes. The focus of a dietary approach to 
treatment is to achieve blood glucose goals without excessive hypoglycaemia (low blood 
glucose levels; Silverstein et al., 2005). The diet has a direct effect on blood glucose 
levels, and the amount of insulin taken must correlate to the amount of carbohydrate 
consumed. 
 
Whilst the long-acting insulin regimens require the individual to have a rigid and routine 
diet, the intensive insulin injection regimens allow more flexibility. The amount of 
carbohydrate in each meal or snack must be calculated and the insulin requirement is 
adjusted to suit the meal (DAFNE Study Group, 2002). However, individuals must not 
only take into account the amount of carbohydrate in a meal, but also its glycaemic 
index (Rendell, 2000). Carbohydrate-rich foods can take varying amounts of time to 
affect blood glucose levels, depending on their fat and fibre composition. High sugar, 
low fibre foods will raise blood glucose levels quickly and are therefore good for 
treating hypoglycaemia. However, slower-acting carbohydrates, such as those containing 
fibre or low glycaemic index are preferable for day-to-day consumption to avoid sharp 
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increases in blood glucose levels. These foods are therefore recommended to reduce the 
risk of postprandial hyperglycaemia (high blood glucose levels; Rendell, 2000). 
Adolescents must be acutely aware of the food they are consuming and its possible 
impact on their blood glucose. This may take a great deal of education and support from 
diabetes teams and family. If the adolescent were to miscalculate their food intake, it is 
likely to lead to acute complications (hypo- or hyperglycaemia). 
 
Alcohol can have a significant effect on blood glucose levels. Initially leading to a sharp 
rise in blood glucose, alcohol has a hypoglycaemic effect and can subsequently lead to 
severe hypoglycaemia up to 24 hours after consumption. This is important within the 
adolescent context, when young people are more likely to experiment with alcohol 
within social settings. The signs of hypoglycaemic attacks are often identical to the signs 
of excessive alcohol consumption and therefore can result in serious and fatal 
consequences untreated. It is vital therefore, that peers are aware of the increased risks 
and complications for adolescents with diabetes and are available to support them, 
should they become hypoglycaemic. 
 
Diet also has important long-term consequences for adolescents with diabetes. People 
with diabetes have a significantly greater risk of coronary heart disease, cerebro-vascular 
disease, and peripheral vascular disease than the general population (Turner & Wass, 
2002). Most people with diabetes will die from one of these diseases (Cull et al., 2007). 
During adolescence, the family is largely responsible for menu planning and therefore 
has a role to support the individual in informed diet choices. Increasingly, adolescents 
spend more time socialising with peers, and this also has clear implications for the 






It is vital that diet is considered seriously as an important aspect of diabetes management 
to prevent acute and chronic complications. The type and amount of food consumed 
must be carefully considered when calculating the required insulin dose, and therefore 
requires support from others whilst adolescents take on the responsibility for themselves.  
Exercise 
Whilst exercise offers a number of health-promoting benefits for all people, the benefits 
for those with diabetes are of particular importance. The American Diabetes Association 
technical review (Wasserman & Zinman, 1994) highlights a number of benefits, 
including an improved lipid profile, increased sense of well-being, weight control and 
improved cardiovascular fitness. In adolescence, exercise appears to have particular 
benefits on lipid and lipidprotein levels (Austin et al., 1993) 
 
Exercise also has a direct effect on blood glucose levels. Approximately 20% of all 
hypoglycaemic attacks in adolescence are associated with exercise, which is usually of 
unexpected intensity, duration or frequency (Silverstein et al., 2005). When exercise is 
commenced with pre-existing hyperglycaemia, it can actually increase the level of blood 
glucose due to the release of glycogen from the liver. Less than six hours after exercise, 
however, hypoglycaemia can occur due to hepatic glycogen depletion (Macdonald, 
1987; SIGN, 2001). It is vital that adolescents taking part in exercise frequently monitor 
their blood glucose and treat accordingly. During adolescence, exercise is often 
undertaken as a social activity with peers (Field et al., 2001). Therefore, whomever the 
adolescent is exercising with should also be aware of the risks of hypoglycaemia and be 






Exercise has a clear impact on long-term health and immediate effects on blood glucose, 
thus requiring more intensive blood glucose monitoring. Exercise is most often 
experienced within social settings with peers. Therefore additional support required for 
hypoglycaemia is more likely to be provided by peers than family. 
1.3.2 Acute health difficulties associated with type 1 diabetes 
There are many factors which may disrupt an adolescent’s ability to maintain stable 
blood glucose levels including exercise, unexpected changes to the diet, stress and 
illness. These result initially in acute health difficulties such as hypoglycaemia (lack of 
glucose in the blood) or alternatively can raise the blood glucose (hyperglycaemia), and 
in the absence of sufficient levels of insulin can lead to DKA. Both these difficulties can 
be effectively treated in their early stages, but require hospital admission if left 
untreated. Therefore it is important to consider these acute difficulties and the support 
that may be beneficial to the adolescent to prevent such difficulties escalating into 
serious medical emergencies. 
Hypoglycaemia 
The wish to avoid hypoglycaemia is one of the major barriers to achieving good 
metabolic control (Cryer, 2002). Hypoglycaemia is defined by insufficient blood glucose 
levels as a result of diet, exercise, illness, or stress (Bennett Johnson et al., 2000) and is 
classified by blood glucose levels below 3-4 mmol/L (Cryer et al., 2003). 
 
Initial symptoms usually include sweating, nausea, tremor, shivering and palpitations. 
These are followed by confusion, tiredness, headache, lack of concentration, dizziness, 
lack of coordination and aggression (Turner & Wass, 2002). If not treated, 
hypoglycaemia may lead to seizures, coma and even death. Unfortunately, severe 
hypoglycaemic attacks are relatively common for all young people with diabetes (Davis 
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et al., 1997). The early signs of hypoglycaemia can be treated simply with a high sugar 
snack. However, if left untreated or unnoticed, the adolescent may require an 
intramuscular injection delivered by medical or paramedic staff. 
 
At the developmental stage of adolescence, young people are often striving for 
autonomy. The need for additional support from peers or family is frequently required 
but might affect the adolescent’s sense of independence. Hypoglycaemia is most likely 
to occur after social activities such as exercise; therefore peers are often in a better 
position to provide support for hypoglycaemia awareness and treatment. Many young 
people understandably fear the possibility of hypoglycaemia and will under-dose their 
insulin to prevent such attacks, but this is associated with serious and chronic 
complications such as blindness and renal failure (DCCT, 1993).  
Diabetic Ketoacidosis (DKA) 
Acidic ketones are produced in the liver when there is an absolute lack of insulin in the 
blood, as attempts are made to source energy from the body’s own stores. This leads to 
polyuria, polydypsia and weight loss. More immediately, young people develop muscle 
cramps, abdominal pain, shortness of breath, nausea, vomiting and severe dehydration 
(Turner & Wass, 2002). Coma is common and can lead to permanent cell death and 
mortality if untreated.   
 
The most common cause for DKA is insulin omission and therefore highlights the 
importance of regular and sufficient insulin delivery (Smith et al., 1998). If young 
people fail to take their insulin, it is likely that DKA will develop and hospitalisation 






Hypoglycaemia is a lack of sufficient blood glucose. It is relatively common and can be 
prevented by the under-dosing of insulin, but this has serious long-term health 
consequences. Young people with diabetes require the external support of family or 
peers who are aware of the signs and symptoms. Either peers or family may need to 
intervene when necessary to prevent serious consequences such as coma. DKA most 
commonly results from insulin omission and has serious and life threatening 
consequences. Family or peer support may therefore ensure that insulin injections are 
remembered and adhered to. 
1.3.3 Chronic complications of type 1 diabetes 
A number of severe and chronic complications are implicated with diabetes. They are 
often referred to as macro-vascular (referring to damage to the large blood vessels in 
organs including the heart), or micro-vascular (damage of small blood vessels including 
those in the eyes, kidneys or nerves). These potential complications are often a focus of 
diabetes care and therefore are vital to consider when examining an adolescent’s 
diabetes management.  
 
Cardiovascular disease and peripheral vascular disease are leading causes of poor health 
and death in adults with type 1 diabetes and are present for some patients in adolescence 
(DCCT, 1994; Jarvisalo et al., 2002). 
 
Retinopathy (damage to the eyes) is the most common micro-vascular complication of 
diabetes and the most common cause of blindness in the working population of 
developed countries (Turner & Wass, 2002). The UK Prospective Diabetes Study 
indicated that most patients with type 1 diabetes develop evidence of retinopathy within 
20 years of diagnosis (Cull et al., 2007; Watkins, 2003). However, 34-42% of 
adolescents may already have background levels of retinopathy (DCCT, 1994).  
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Nephropathy (damage to kidneys) is a major cause of premature death in patients with 
all types of diabetes (Turner & Wass, 2002). It is identified by abnormal protein 
excretion from the kidneys. Whilst this can sometimes be reversible at very early stages, 
left untreated it can progress to total renal failure (Perkins et al., 2003).  
 
Neuropathy describes the injury to peripheral nerves from hyperglycaemia (Fowler, 
2008). Typically patients experience burning, tingling and ‘electrical’ pain, or simple 
numbness. There is an increased risk of foot ulceration, which can lead to amputation if 
not treated. Neuropathies can also affect organ systems, leading to reduced food 
absorption, increased risk of hypo- and hyperglycaemia, and hypoglycaemia 
unawareness (Trotta et al., 2004). 
 
The Diabetes Control and Complications Trial clearly identified that all macro- and 
micro-vascular complications could be treated with improved metabolic control (as a 
result of frequent blood glucose monitoring and the maintenance of stable blood glucose 
levels), and attention to diet and exercise guidelines (DCCT, 1994; National Cholesterol 
Education Program, 1992). In some cases, the prevalence of complications were 
decreased by 38-59% following improvement in metabolic control (DCCT, 1994). 
Whilst improved metabolic control has a role in the treatment of complications, it is also 
vital in their prevention (DCCT, 1994; Trotta et al., 2004). One of the main aims of 
diabetes management for adolescents is to prevent future complications through regular 
monitoring and adherence to diabetes management tasks. Maintaining stable blood 
glucose levels is not an easy task for adolescents and requires additional support from 
both family and peers. This might include reminding adolescents to take insulin or test 
blood glucose, and assisting in the prevention or treatment of acute complications 




Type 1 diabetes is a chronic, irreversible disease, characterised by the autoimmune 
destruction of insulin-producing pancreatic cells. Chronic hyperglycaemia therefore 
results and can be fatal in the absence of subcutaneous insulin injection. The aim of 
diabetes treatment is to maintain blood glucose levels as close to the ‘normal’ range as a 
possible, avoiding hypo- or hyperglycaemia. To achieve this, patients must adhere to a 
complex and intensive treatment regimen including insulin injections or continuous 
insulin infusion, blood glucose monitoring, diet, and exercise. Almost constant 
monitoring is required to ensure that changes in blood glucose level are identified and 
treated appropriately. Serious complications can result if blood glucose levels are not 
maintained at the recommended level. It is therefore important that young people are 
supported by family and peers with all the required diabetes management tasks. This 
might include reminders for blood glucose testing, or practical support in terms of the 
provision of testing equipment or appropriate menu choices. As acute complications 
such as hypoglycaemia are common, peers are also likely to be involved in adolescents’ 
treatment.  
1.4 Metabolic control 
The aims of all diabetes treatments are to stabilise blood glucose levels to a ‘near 
‘normal’ level of 4-10 mmol/L. To obtain a picture of the longer-term level of diabetes 
control (metabolic control), a blood test can be taken at the diabetes clinic, which 
provides the glycated haemoglobin level, or HbA1c. The HbA1c provides an objective 
measure of the average blood glucose concentration over the last 120 days. When 
glucose molecules bond to haemoglobin within the red blood cells, glycated 
haemoglobin is formed. Therefore the greater the amount of glucose present in the red 
blood cells during their 120 day life span, the higher the HbA1c level (expressed as the 
percentage of the normal haemoglobin range). The reference range (that found in the 
general population) is approximately 4-5.9%. The DCCT recommended that for patients 
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with diabetes, HbA1c results should remain lower than 7.5% to prevent diabetes-related 
complications (DCCT, 1993).  
 
Internationally, the current policy guidelines strongly recommend the use of the HbA1c 
as the ‘gold standard’ for the objective measurement of metabolic control (ADA 
Consensus Committee, 2007; DCCT, 1993). As a result it is the only measurement 
routinely used within Scottish diabetes teams.  
 
Within Scotland, the average HbA1c result was found to be 8.9% for children and 9.4% 
for adolescents (Greene & Waugh, 2004), significantly above the recommended 
guidelines, and placing young people at an increased risk of complications. The National 
Paediatric Diabetes Audit (Diabetes UK, 2002) reported that the average HbA1c result 
for children in England was 8.6% and 9.2% for adolescents (9.0% in Northern Ireland). 
International studies report a mean HbA1c for adolescents of 9.1% in New Zealand 
(Scott et al., 2006). Within the UK, the average HbA1c for adults was 7.9% (American 
Diabetes Association, 2002). These results support the known deterioration in HbA1c 
with age from childhood to adolescence (Greene & Waugh, 2004). The Scottish HbA1c 
data indicates that metabolic control is comparable in this population to other 
international groups. The HbA1c, however, remains at a level predictive of future 
complications and therefore it is important to study this population to identify any 
factors that may explain this deterioration in HbA1c, and thereby attempt to develop 
possible solutions.  
1.4.1 Summary 
Metabolic control refers to the extent to which blood glucose levels are maintained 
within a recommended range. Metabolic control has been identified as the strongest 
predictor of future complications. It is highly likely that young people diagnosed with 
diabetes will at some point develop either acute or chronic complications due to their 
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diabetes, but these risks can be dramatically reduced through intensive monitoring and 
treatment adherence. It is also widely recognised that adolescents with type 1 diabetes 
have significantly poorer metabolic control than both children and adults.  
1.5 Quality of life 
1.5.1 Quality of life and health related quality of life 
Despite the growing importance of quality of life within diabetes care (DCCT, 1993; 
Delamater, 2000) and other chronic medical conditions, it still remains a poorly defined 
concept. The World Health Organisation (World Health Organisation, 1995, p.1405) 
defined quality of life as “individuals’ perception of their position in life in the context 
of the culture and value systems in which they live and relation to their goals, 
expectations, standards and concerns”. Even without a universally accepted definition, 
quality of life remains, within the western world, a familiar concept that encompasses 
components such as happiness and satisfaction with life (Fayers & Machin, 2007). 
 
Within a health context, the term ‘health-related quality of life’ (HRQOL) is regularly 
used to describe a patient’s sense of his or her own health and well-being in the broad 
areas of physical, psychological and social functioning (Petersen et al., 2006; Polonksy, 
2000). There has been an increasingly strong interest in examining HRQOL as an 
outcome to medical intervention and research (Polonksy, 2000). This highlights the shift 
in focus upon which medical teams reflect, towards being led by the patients’ own 
experiences of how their health care is affecting their immediate and future well-being. 
As a result, medical teams are therefore being encouraged to consider their patient’s 
welfare in a broader context. 
 
Whilst HRQOL is clearly a multidimensional construct, it has traditionally been 
evaluated using one-dimensional questionnaires that might take into account 
psychological distress such as depression, functional limitations in daily life or the 
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burden of physical symptoms (Polonksy, 2000). Measures such as the Medical 
Outcomes Study SF-36 and Child Health Questionnaire (CHQ) have typically been used 
due to their popularity in previous research. They allow for comparison between patients 
with and without disease and can take into account existing co-morbidities. However 
these measures are typically less sensitive to changes in disease and have been found to 
under-represent the impact of disease on young people (Cameron, 2003; Graue et al., 
2003).  
1.5.2 Diabetes-specific quality of life 
Disease-specific quality of life is defined by the extent to which a patient’s sense of their 
particular disease might compromise their general well-being in three areas of 
functioning: physical, psychological and social. 
The impact of diabetes on quality of life 
Physical functioning can be influenced by diabetes in three main ways. First, the 
development of chronic complications such as loss of sight and chronic pain are likely to 
lead to a drop in quality of life. These difficulties may lead to a reduced ability to attend 
school, or enjoy pleasurable activities, and reduce their sense of autonomy as a 
developing adolescent. Second, acute difficulties such as hypoglycaemia are likely to 
affect an adolescent’s sense of well-being. Finally, the diabetes management regimen 
itself may force adolescents to limit their activities. This might include being unable to 
spontaneously eat at a restaurant, or attend sleepovers, thus reducing their quality of life. 
 
Psychological functioning such as mood difficulties can be significantly affected by 
diabetes. The disease regimen can cause a sense of ‘learned helplessness’ as their best 
efforts to control their diabetes may be unsuccessful due to physiological changes 
associated with puberty (Kuttner et al., 1990). Most young people with diabetes 
experience anxiety, low mood or social withdrawal, although psychological symptoms 
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per se are not detrimental to diabetes care (Gonder-Frederick et al., 2002). Anxious 
patients are hypothesised to be more ‘diligent in monitoring’ their diabetes (Bryden et 
al., 2001, p.1539). It is therefore important that the individual’s perceptions of quality of 
life are considered in addition to metabolic control as a clinical outcome. 
 
Social functioning can be affected by diabetes through the quality and quantity of a 
patient’s relationships. Friends or peers may act as the “diabetes police” (Roszler, 2005, 
p.1), encouraging self-care changes even if the patient is unwilling to accept them. This 
may lead to conflict and a sense of loneliness for young people with diabetes. Social 
situations such as parties may become fraught with conflict as young people seek to gain 
acceptance in a peer group, and are subsequently pressured by peers to take part in 
behaviours that might be harmful to their diabetes management (Polonksy, 2000). Social 
functioning is therefore particularly important in the developmental context of 
adolescence when young people are striving for independence from family and a greater 
reliance on peers for support and intimacy.  
Measures 
Disease-specific measures have been argued to be of greater value than generic HRQOL 
measures within research because they are more sensitive to change and lifestyle issues 
(Delamater, 2000; Garratt et al., 2002; Polonksy, 2000). Diabetes–specific measures 
have also demonstrated greater accuracy than generic quality of life measures at 
discriminating between respondents with differing metabolic control. It is important to 
take this into account when designing research that investigates both quality of life and 
metabolic control (Huang et al., 2007). The present study has used diabetes-specific 
measures for this reason.  
 
The first diabetes-specific quality of life measure for young people was developed in 
response to the DCCT research group (Ingersoll & Marrero, 1991). There are a number 
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of empirically validated paediatric HRQOL instruments to include specific adolescent 
measures. The Disabkids wass developed for use with young people aged between 4 and 
16 and has specific diabetes modules (Baars, Atherton, Koopman, Bullinger & Power, 
2005). The Kidscreen covers the age range of 8-18 years but does not include specific 
diabetes modules (Robitail et al., 2006). Most recently, the Paediatric Quality of Life 
Inventory (PedsQL) was developed, including a diabetes-specific measure (Varni et al., 
2003), which has demonstrated both sensitivity and responsiveness. The PedsQL 
adolescent measure has a specific diabetes module and is developed for 13 to 18 year 
olds. For these reasons, the PedsQL diabetes module has been used in the present study. 
1.5.3 Summary 
HRQOL is an important tool in the measurement of clinical outcome within diabetes 
populations. Increasingly diabetes teams are placing more emphasis on the impact of 
diabetes and its treatments on the individual’s sense of well-being as well as attempting 
to prevent chronic complications and maintain good metabolic control. Within the 
context of adolescent development, three areas of quality of life are of particular 
importance. Physical functioning takes into account the consequences of the chronic 
condition and the need for intensive monitoring. Psychological functioning however, can 
be affected greatly by the demands of the medical regimen, which can lead to a sense of 
learned helplessness and lowered mood. Finally, social functioning is vital to 
adolescents’ sense of autonomy, identity and belonging. As metabolic control is strongly 
associated with quality of life, it is therefore important to evaluate both within the 
clinical and research setting. Diabetes-specific measures appear to hold greater 
sensitivity and validity for the adolescent population and are therefore recommended for 
research and clinical use. 
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1.6 The developmental context of adolescence 
Change is often seen as a defining feature of adolescence, as many physical, 
psychological and social changes affect the young person’s experience of life and their 
development and transition to adulthood (Holmbeck, 2002). Any research with 
adolescents must take into account the unique developmental changes associated with 
this life stage. Investigating the health and well-being of adolescents is important due to 
the magnitude and number of physical, psychological and social changes, second only to 
those found in infancy (Feldman & Elliott, 1993). 
 
It is important, therefore to consider any health and well-being evaluations within the 
context of normal adolescent development. A biopsychosocial framework has been 
proposed (Figure 1) for understanding adolescent development and adjustment, as well 




Figure 1: Framework for understanding adolescent development and adjustment (adapted from 
Holmbeck, 2002). 
 
Diabetes may influence the impact of developmental changes on adolescents’ 
experiences of well-being and health. According to this model, the behaviours of 
significant others (i.e., family and peer support) may mediate relationships between 
developmental changes such as puberty or cognitive development, and the adolescent’s 
development of autonomy, independence and identity (Holmbeck, 2002). For example, 
family or peer support may impact on an adolescent’s cognitive ability to prioritise 


































 Family structure 
 Gender* 







 Health status* 
Items marked with * indicate factors relevant to the present study 
Introduction  
 33 
personal health over social acceptance, thereby influencing their adherence to diabetes 
management tasks and consequently affecting their quality of life. Demographic and 
intrapersonal variables, such as diabetes health status, may also act as moderating 
factors, influencing the strength and direction of relationships between family and peer 
support and the development of autonomy, independence and identity.  
1.6.1 Summary 
Many physical, psychological and social changes associated with normal adolescent 
development may be relevant to the investigation of the impact of family and peer 
support on both quality of life and health status. When considering diabetes in a 
developmental framework, it is important to take into account the role of interpersonal 
factors such as family and peer support on the developmental outcomes of adolescence. 
Should these developmental outcomes be limited by social support factors or diabetes 
health status, it has significant implications for adolescent development, and quality of 
life. 
1.7 Family support 
At present there is no specific guidance as to how families can be involved in their 
adolescent’s diabetes care. The SIGN guidelines state that “parental support and family 
communication should be encouraged”, however specific forms of support are not 
identified or suggested (SIGN, 2001, p.5). The NICE guidelines also identify that 
families should be offered access to mental health professionals because they may 
experience family conflict that can impact on the management of diabetes and well-
being (NICE, 2004). It is important therefore to identify sources of support and potential 
difficulties for the family that can impact on an adolescent’s metabolic control and 
quality of life. 
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1.7.1 Family support and adolescence 
Adolescence is defined as the transition between childhood and adulthood, where the 
young person ultimately aims to develop a sense of autonomy, identity, achievement and 
intimacy (Figure 1; Holmbeck, 2002). To develop a sense of identity, adolescents strive 
to achieve independence from their family and redefine themselves as autonomous, 
rather than dependent. However, as the term ‘transition’ implies, this is not a clear cut or 
easy process and requires adaptation from both the young person and their family. Until 
adolescence, families are almost entirely responsible for the safety, development and 
care of the young person. Therefore a shift from parental control to a more mutual and 
collaborative decision-making process is required (Youniss & Smollar, 1985). This 
shifting of control, along with the biological, psychological and social changes 
associated with adolescence, inevitably involves a renegotiation of roles and 
reorganisation of family relationships (Allison & Schultz, 2004). As a result, 
adolescence can be fraught with conflict as both the family and adolescent test the 
boundaries of safety and autonomy (Leonard et al., 2005). These conflicts often centre 
around mundane recurring events (Montemayor & Hanson, 1985) but are important for 
negotiation and boundary setting within the family. 
 
Whilst the family context can be fraught with conflict, it is important to highlight the 
positive and protective aspects of family life for the adolescent. Parental warmth has 
been shown to be a vital component of an adaptive parent-adolescent relationship. This 
refers to the emotional nurturance and affection given by the parent to the adolescent 
(MacDonald, 1992) and research has indicated that parental warmth is associated with 
reduced psychological distress and less anti-social behaviour in adolescents (Pettit et al., 
1997). During the transition towards relinquishing control over the adolescent, parental 
monitoring has been found to be important for reducing risk behaviours and increasing 
adolescents’ sense of safety and well-being (Li et al., 2000). The balance between 
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maintaining safe boundaries in a warm and caring environment and allowing the 
adolescent to explore these limits for themselves is an inevitable challenge. 
1.7.2 Family support and diabetes 
Adolescents with diabetes face the same developmental tasks and family conflicts as any 
other adolescent. Studies have shown that the quantity, intensity and frequency of 
conflicts are similar in families with and without diabetes (Viikinsalo et al., 2005). 
However, research into the family context of adolescent diabetes has typically focused 
on conflict and its impact on the adolescent’s sense of autonomy. Studies indicate that 
poor family cohesion, high family conflict and critical or negative parenting leads to 
poorer treatment adherence for adolescents with diabetes (Dashiff et al., 2008; Duke et 
al., 2008; Kyngas, 1999; Lewandowski & Drotar, 2007; Lewin et al., 2006) This 
indicates that the family emotional environment is important for adaptive diabetes care. 
 
The addition of a chronic illness at this life stage also brings its own challenges. The 
transition from dependence on family to independence and responsibility for self-care is 
just as salient in terms of diabetes management. In childhood and early adolescence, 
diabetes treatment is mainly the responsibility of the family and parents, ensuring stable 
blood glucose levels and providing an adequate diet and exercise (Leonard et al., 2005). 
Ultimately, the individual must be responsible for their own diabetes management. This 
shift in responsibility is a difficult one for both adolescent and family, particularly as this 
may come of necessity as adolescents spend more time with peers. Ideally, the 
renegotiation of roles and responsibility within adolescence should be developmentally 
appropriate and timely for each individual (Aanstoot et al., 2007; Wiebe et al., 2005). 
However, these changes occur much earlier for adolescents with diabetes than their 
peers due to the requirement for adolescents to continue diabetes–specific care tasks in 
social situations away from the family (Leonard et al., 2005). Therefore, a 
developmentally premature shift to autonomy and responsibility for adolescents’ 
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diabetes care is likely to lead to poorer metabolic control (Wiebe et al., 2005). 
Conversely, continued parental assistance when adolescents are attempting to become 
independent can lead to a sense of incompetence for the young person (Helgeson, 
Reynolds, Siminerio, et al., 2007). Achieving this balance is difficult and often leads to 
conflict when adolescents do not achieve the recommended diabetes targets. 
1.7.3 Family support and metabolic control 
Despite the shift away from family responsibility for diabetes care during adolescence, a 
number of family factors have been associated with metabolic control. Conflict related 
to diabetes management tasks strongly predicts poor metabolic control (Dashiff et al., 
2008; Kyngas, 1999; Lewandowski & Drotar, 2007). Research investigating the role of 
family factors such as marital status of parents has indicated that adolescents of single 
parent families are more likely to have poor metabolic control. This was mediated, 
however by the number of diabetes management tasks (blood glucose monitoring) 
completed each day (Urbach et al., 2005). Lower parental intelligence and knowledge 
have also been associated with poor metabolic control (Ross et al., 2001; Stallwood, 
2006). Adolescents who are classified as having good metabolic control have higher 
parental involvement in their care (Gowers et al., 1995). It appears that the parent’s 
ability and opportunity to provide diabetes-related care has a significant impact on the 
metabolic control of the young person.  
 
Upon further examination of family involvement in diabetes care, the evidence 
overwhelmingly states that increased supervision and practical support of diabetes care 
tasks predict better metabolic control for adolescents (Ellis, Yopp et al., 2007; Lewin et 
al., 2006). More specifically, family involvement in adherence to treatment such as 
blood glucose monitoring appears to be a strong predictor of metabolic control even if 
the adolescent has been diagnosed for many years (Anderson et al., 1997; Ellis, Podolski 
et al., 2007; Wiebe et al., 2005). However, studies indicate that if the family are 
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perceived to be ‘nagging’, this can lead to poorer metabolic control (Leonard et al., 
2005). 
1.7.4 Family support and quality of life 
While family support for diabetes care tasks is clearly linked to metabolic control, it is 
important to consider the effects of such continued family control on the adolescent’s 
well-being and developmental outcomes. Holmbeck’s (2002) model (Figure 1) 
highlights the importance of the development of autonomy and psychosocial adjustment. 
Parents of adolescents with diabetes have been found to be more involved in the young 
person’s free time and activities than parents of adolescents with other illnesses such as 
arthritis (Graue et al., 2005). There are two main components to family support for 
diabetes: (a) the practical and instrumental monitoring and support for diabetes related 
tasks (such as ensuring blood glucose monitoring takes place) and (b) the emotional 
support for coping with a chronic illness. 
 
Continued practical involvement in diabetes-specific tasks by family during adolescence 
has not been shown to affect quality of life for these young people per se. Conflict 
associated with such involvement, however, is associated with poorer quality of life 
(Laffel et al., 2003).  
 
Adolescents report that practical support for diabetes care, such as checking blood 
glucose with the family before a meal, can bring the family closer together, reduce 
conflict and make the tasks easier to remember and complete (Leonard et al., 2005). 
However, adolescents attributed frequent conflict and arguments with parents to 
difficulties managing their diabetes (Leonard et al., 2005). When parental involvement 
is perceived to be ‘controlling’ rather than ‘collaborating’, there is a greater likelihood 




Family support for diabetes has typically focused upon practical diabetes-related tasks. 
As a result, the impact of emotional support by the family has been understudied. The 
existing literature proposes that emotional support may be predictive of enhanced quality 
of life (Delamater, 2000; Grey et al., 1998; La Greca & Bearman, 2002) but there is 
need for further research. When examining the experience of diabetes for a young 
person within the family context it is therefore important to be aware of the emotional, 
as well as the practical, support given. 
1.7.5 Measures 
There are a number of existing measures that identify the diabetes-specific support given 
by families. These include both the Diabetes Family Behaviour Checklist (DFBC) and 
the Diabetes Family Behaviour Scale (DFBS), which examine the frequency of practical 
support for meals, blood glucose monitoring, insulin management and exercise. 
However, these measures do not include emotional support, which might be important in 
terms of quality of life for young people (McKelvey et al., 1989; Schafer et al., 1983). 
La Greca & Bearman (2002) developed and evaluated the Diabetes Social Support 
Questionnaire – Family Version (DSSQ-Family) for adolescents with diabetes. This 
measure is directly comparable with a version for peers, and includes items that identify 
both practical and emotional support and will therefore be used within the present study. 
1.7.6 Summary 
The transition between childhood and adulthood for all adolescents within the family 
context is often conflictual and fraught due to the shift from parental control to 
autonomy and independence. However, when a young person has diabetes, it appears 
that such conflict is qualitatively different and may have severe consequences for 
diabetes-related health and quality of life. There appears to be a difficult balance that 
must be sought between continued family involvement in diabetes care (associated with 
better metabolic control) and the young person’s independence and psychosocial 
adjustment (that might improve quality of life). 
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1.8 Peer support 
1.8.1 Peer support in adolescence 
Normal adolescent development includes the formation of a social network that leads to 
more intimate relationships (Seiffge-Krenke, 2001). One of the many changes within 
adolescence includes the separation of young people from families, and seeking and 
maintaining close relationships away from the family home. Experiences within a peer 
group are important for developing autonomy and a sense of identity (Youniss & 
Smollar, 1985). However, having a high status in a peer group has not been found to be 
as important for psychological well-being as having a best friend (Parker & Asher, 
1987). Having a close friendship becomes increasingly important through adolescence. 
Peer group acceptance is clearly important to adolescent development, but as young 
people develop, the quality of relationships are more important for psychological 
adjustment than the number of friends within a network (Frankel, 1990). A friend’s 
ability to be emotionally supportive is thought to be important in the confrontation of 
developmental tasks and role transitions for general psychological well-being (Seiffge-
Krenke, 2001). Both close friends and the wider peer group will be considered and 
subsequently referred to as ‘peers’ in this study. 
1.8.2 Peer support and diabetes 
When discussing adolescent development in the context of chronic illness, surprisingly 
little attention has been paid to the role of peer relationships (Patterson & Garwick, 
1998). Additionally, no clinical guidance is available concerning the involvement of 
peers in adolescent diabetes care. One study, however, examined the friendships of 
adolescents with and without diabetes and followed them for four years (Seiffge-Krenke, 
2000). Both groups of adolescents reported similar numbers of close friends. A more 
recent study reported that adolescents with diabetes were equally likely to have a best 
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friend and boyfriend/girlfriend and that similar levels of support were reported for 
adolescents with and without diabetes (Helgeson, Reynolds, Escobar et al., 2007).  
 
Friendships do not appear to be fundamentally different for adolescents with or without 
diabetes. However, within a diabetes population, higher rates of victimisation and lower 
levels of pro-social support have been found (Storch et al., 2004). This is reported by 
adolescents as due to “being different [than non-diabetics]” (Kyngas & Barlow, 1995 
p.943). As peer group affiliation and social acceptance are a central aspect of adolescent 
development, being ‘different’ can be detrimental to an adolescent’s sense of identity 
(Kyngas & Barlow, 1995). Health-risk behaviours are strongly associated with the close 
friendships and peer groups with which a young person is affiliated. For example, in a 
study based in the USA, those identifying themselves as ‘Jocks’ were more likely to 
engage in risky sexual behaviour, whereas ‘Brains’ were least likely to engage in any 
health–risk behaviours (La Greca et al., 2001). More recently, peer affiliation has also 
been found to have a strong influence on eating behaviours and exercise, two major 
components of diabetes management (Mackey & La Greca, 2007). These studies 
highlight the role of peer influence over adolescents’ health behaviours. As has been 
illustrated, this is of particular importance in diabetes management. Thus, the role of the 
peer group, including friendships, is key to examining support for diabetes-related tasks. 
1.8.3 Peer support and metabolic control 
Adolescence brings cognitive changes that are potentially both positive and detrimental 
to diabetes management. Cognitive changes in later adolescence include the ability to 
problem solve and be aware of future consequences of behaviours that might increase 
the likelihood of better diabetes management and better metabolic control. However, 
these cognitive changes also enable the adolescent to choose their own personal 
priorities. This can include the prioritisation of peer affiliation over diabetes 
management tasks and their future health (Holmbeck, 2002). The degree to which an 
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adolescent’s peers are supportive of the completion of diabetes management tasks 
appears to buffer an adolescent’s cognitive ability to make adaptive decisions about their 
diabetes care (Holmbeck, 2002). 
 
Diabetes management tasks such as blood glucose monitoring and insulin management 
are likely to differentiate adolescents with diabetes from their peers in social settings. It 
is not surprising therefore, that adherence to these tasks is more difficult in such contexts 
(Hains et al., 2007). Poorer adherence in social settings is dependent on negative 
attributions made about the peer’s reactions rather than the peer’s presence per se (Hains 
et al., 2006). Therefore, if peers are supportive of the adolescent’s diabetes management, 
diabetes tasks (e.g., blood glucose monitoring and insulin management) may interfere 
less with peer relationships or social acceptance. As adherence to blood glucose 
monitoring and insulin management strongly predicts metabolic control, it is important 
to consider the adolescent’s perceptions of their social support. 
 
Peers have been reported to provide more emotional support (e.g., when adolescents 
with diabetes are asked questions such as “How often do your peers understand when 
you sometimes make mistakes in taking care of your diabetes”) than practical support 
(e.g., when adolescents with diabetes are asked questions such as “How often do your 
peers remind you to take your insulin”) (DSSQ- Friends questionnaire; Bearman & La 
Greca, 2002, p.421; Helgeson et al., 2006; La Greca et al., 1995). The lower frequency 
of practical support given by peers was investigated using a peer group intervention 
(Greco et al., 2001). It was found that even when peer knowledge about diabetes and 
diabetes-related tasks was increased, the amount of practical support did not increase, 
nor did adherence.  
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1.8.4 Peer support and quality of life 
In a qualitative study by Kyngas and Barlow (1995), adolescents were asked to describe 
their experiences with a chronic illness. Diabetes was described as “hell”, “a nightmare” 
and “prison” (p.943). This highlights the negative psychological and social implications 
of diabetes (Kyngas & Barlow, 1995). Adolescents with diabetes also reported increased 
“stress and concern for the future” (Kyngas & Barlow, 1995, p.943). Psychological 
distress associated with diabetes therefore has an important impact on quality of life for 
the individual. However, peer emotional support has been found to serve a protective 
function for psychological health and well-being when faced with the demanding and 
chronic nature of diabetes (Hains et al., 2007; Helgeson, Reynolds, Escobar et al., 
2007).  
 
Adolescents with diabetes miss twice as much school as their peers without diabetes 
(Ryan et al., 1985), therefore missing out on opportunities for peer group activities, 
socialisation and acceptance. This consequently may limit the individual’s ability to 
make and maintain supportive relationships with peers and restrict their quality of life. 
 
Peers have an important role in providing emotional support for adolescents (Skinner et 
al., 2000). However, negative peer relationships can have serious and detrimental effects 
on both psychological and physical health for the adolescents with diabetes (Helgeson, 
Reynolds, Escobar et al., 2007). If adolescents make negative attributions of their peer’s 
reactions to diabetes, it is more likely to lead to increased diabetes-related stress (Hains 
et al., 2006). These negative attributions (e.g., “I’d think my friends wouldn’t like me 
anymore”; Hains et al., 2006, p.820) are more likely if the adolescent has experienced 
similar peer reactions in the past and is subsequently apprehensive about being singled 
out by others (Hains et al., 2006). Such attributions could lead to psychological distress 




Paradoxically, high levels of perceived peer support have been associated with poor 
health outcomes such as metabolic control, whilst indicating higher levels of quality of 
life (Greco et al., 2001). This can be partly explained by the nature of the support given. 
To fit in with a peer group, adolescents may want their peer group to “treat [them] like 
anyone else” in terms of social functioning, acceptance and identity (Shroff Pendley et 
al., 2002 p.435). However this may mean that diabetes tasks are neglected, leading to 
poorer health outcomes. It is important, therefore, to identify the nature of support given 
by peers when considering metabolic control and quality of life. 
1.8.5 Measures 
Measures have been developed to examine general peer support in adolescence 
(Procidano & Heller, 1983), but there is limited research that attempts to examine the 
role of diabetes-specific peer support in metabolic control and diabetes-related quality of 
life. The Diabetes Social Support Interview-Peers (DSSI-P) was developed to identify 
the specific aspects of support given by peers for diabetes (La Greca et al., 1995). To 
study the specific ways that adolescents’ peers provide support, the Diabetes Social 
Support Questionnaire (DSSQ-Friends) was developed from the DSSI. Advantages to 
using a questionnaire format rather than interview includes the shortened time taken to 
administer and score the measure. The DSSI requires the adolescent to recall specific 
support behaviours. However, adolescents typically find recall more difficult than 
recognition, and therefore may be more likely to miss important support behaviours 
during an interview (Bearman & La Greca, 2002). The DSSQ-Friends will be used in the 
present study for these reasons. 
1.8.6 Summary 
Peer support has been found to be both helpful and detrimental to adolescents’ 
experiences of diabetes, depending on the nature of the support given and its context. 
Adolescents with diabetes must balance normal adolescent development aims such as 
group affiliation and acceptance with intrusive and intensive diabetes management tasks. 
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It appears that peers are more likely to offer emotional support, which is beneficial in 
terms of buffering psychological difficulties and enhancing quality of life. However, in 
doing this, peers might also encourage fewer diabetes-adherent behaviours and promote 
detrimental health outcomes. It is important, therefore, to identify the nature of support 
given by peers before examining its relationship to quality of life and metabolic control. 
1.9 Family and peer support 
Family support appears to be more practical in nature than emotional (La Greca et al., 
1995; Shroff Pendley et al., 2002), which is predictive of better adherence and metabolic 
control. Peer support, however, appears to be more companionship-related or emotional 
in nature (La Greca et al., 1995; Shroff Pendley et al., 2002) and has been proposed to 
have an impact on quality of life. Few comparative studies have been completed in the 
field of diabetes, and to date, none has examined the role of specific forms of diabetes-
specific family and peer support on metabolic control and quality of life. La Greca et al. 
(1995) and Shroff Pendley et al., (2002, p.435) conducted interview-based studies to 
identify whether “total [diabetes-specific] perceived family support” or “total [diabetes-
specific] perceived peer support” had a greater role on adherence or metabolic control. 
These studies highlight the need for further investigation into the specific ways in which 
family and peers provide support for adolescents and the impact of support types on both 
metabolic control and quality of life. The existing literature (Bearman & La Greca, 
2002; Delamater, 2000; La Greca et al., 1995; La Greca & Bearman, 2002) also 
highlights the need for further study using both objective (metabolic control) and 
subjective (questionnaires of social support and quality of life) measures.  
 
The development of the comparable DSSQ-(Family and Friends versions) has enabled 
the study of diabetes-specific support given by those who most greatly influence the 
adolescent’s diabetes experience. The relative role of the specific areas of support given 
by peers and family for both metabolic control and quality of life can therefore be 
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investigated. As a result, it is hoped that a clearer picture of the specific impact of 
different types and sources of support can be identified. 
1.10  Mood 
The prevalence of depression or depressive symptoms in type 1 diabetes ranges from 
two to three times that of peers without diabetes (Blanz et al., 1993; Kokkonen & 
Kokkonen, 1995). The prevalence of depression in adolescent diabetes ranges 
significantly within the literature from 11% (Grey et al., 1998) to 47% (Kovacs et al., 
1997), depending on the research method employed. Kovacs et al. (1997) highlight that 
the prevalence of depressive symptoms shortly after diagnosis is very high, however this 
falls significantly after 6-12 months. Diabetes appears to be a significant risk factor for 
psychiatric disorders, particularly those characterised by internalising symptoms, such as 
depression (Blanz et al., 1993). Both family factors and peer factors are associated with 
depression in adolescence. Poor family functioning, lack of cohesion and conflict have 
been identified as risk factors (Blanz et al., 1993). Peer group pressure and negative peer 
relations are also significant predictors of low mood (Helgeson, Reynolds, Escobar et 
al., 2007).  
1.10.1 Mood and metabolic control 
It is widely reported and acknowledged that lower mood is associated with poorer 
metabolic control (Delamater et al., 2001; Hood et al., 2006; Lawrence et al., 2006). It is 
suggested that the relationship between mood and metabolic control may be 
bidirectional (Cox & Gonder-Frederick, 1992). Psychological stress can directly affect 
blood glucose through the release of stress hormones, or indirectly by decreasing 
motivation and adherence to diabetes management tasks (Cox & Gonder-Frederick, 
1992). The neuropsychological impact of depression may also impact memory, and 
therefore the ability to remember daily blood glucose monitoring and insulin 
management (de Groot et al., 1999). The physical symptoms associated with hyper- and 
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hypoglycaemia may also induce negative mood states (Gonder-Frederick et al., 2002). 
Whilst most studies have used clinical cut-offs such as the DSM-IV diagnostic criteria 
(American Psychiatric Association, 2000), significant associations with poor metabolic 
control have also been found with sub-clinical levels of low mood (Gonder-Frederick et 
al., 2002). 
1.10.2 Mood and quality of life 
Quality of life is known to be reduced in the presence of depression, independent of 
physical complications (Grey et al., 1998; Jacobson et al., 1997). This is still true of sub-
clinical symptoms in the adolescent diabetes population (Jacobson et al., 1997). 
Depression is more likely for adolescents who struggle to manage the demands of 
diabetes with developmental tasks of adapting to puberty, peer group affiliation, 
independence from parents and identity formation (Delamater, 2007).  
1.10.3 Measures 
Within chronic illness settings, physical aspects of the health condition can be mistaken 
for depressive symptoms. For example, the fatigue and loss of motivation associated 
with hyperglycaemia might be falsely identified as a symptom of depression using 
standard questionnaires such as the Beck Depression Inventory (Beck et al., 1996). 
Questionnaires such as the Hospital Anxiety and Depression Scale (HADS) have been 
developed and validated for adolescent hospital and illness settings and are less likely to 
identify false positives (White et al., 1999; Zigmond & Snaith, 1983).  
1.10.4 Summary 
Depression is a common co-morbidity of diabetes in the young and is associated with 
both family and peer factors. Depression significantly impacts on both metabolic control 
and quality of life, even at sub-clinical levels. When investigating quality of life and 
metabolic control, it is therefore important to consider the potential role of low mood 
using measures that are valid and reliable for the diabetes population. 
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1.11  Aims and hypotheses 
1.11.1 Aims 
The clinical importance of both metabolic control and quality of life in adolescent 
diabetes are apparent. It is also clear that adolescence is defined by the transition from 
childhood and dependence on family to independence and increased importance of 
peers. However, the role of specific forms of support given by both family and peers on 
both metabolic control and quality of life are unclear. The present study aims to 
investigate the nature and impact of support for adolescents (aged 13-18) with type 1 
diabetes in the Tayside, Forth Valley and Fife clinical populations. 
 
Metabolic control remains at unsatisfactory levels for adolescents in Scotland (Greene & 
Waugh, 2004), so it is important to attempt to identify factors that may predict better 
metabolic control in this age group. This study aims to consider the potential impact of 
factors specific to type 1 diabetes (mood, age and insulin management) when examining 
the role of social support in metabolic control and quality of life. It also aims to 
determine the specific source and type of social support given to adolescents, and their 
relationships with both metabolic control and quality of life.  
 
The following questions guide the study: 
 To what extent does diabetes-specific social support provided by family and 
peers predict metabolic control for adolescents with diabetes? 
 To what extent does diabetes-specific social support provided by family and 




Based on previous findings and research, the following hypotheses are presented: 
 
Hypothesis 1: 
Support for practical diabetes management tasks (insulin management, blood glucose 
monitoring and diet) will be provided more frequently by family than by peers. 
 
Hypothesis 1a 




Support for blood glucose monitoring will be provided more frequently by 
family than peers. 
  
Hypothesis 1c 
Support for diet will be provided more frequently by family than peers. 
 
Hypothesis 2: 
‘Companionship’- related support (emotional support and support for exercise) will be 
provided more frequently by peers than family. 
 
 Hypothesis 2a 
Emotional support will be provided more frequently by peers than family. 
 
 Hypothesis 2b 






Family support for management tasks (blood glucose monitoring, insulin management 
and diet) will be more predictive of metabolic control than (a) peer support for 
management tasks (blood glucose monitoring, insulin management and diet), (b) family 




Peer emotional support and support for exercise will be more predictive of diabetes-
related quality of life than (a) family emotional and exercise support, and (b) support for 
management tasks (blood glucose monitoring, insulin management and diet) by both 





2.1 Design  
This study examines the relative role of family and peer support on diabetes-related 
quality of life and metabolic control in adolescent type 1 diabetes. The study is cross-
sectional in design, examining the links between two predictor variables (family and 
peer diabetes-specific support) and two criterion variables (quality of life and metabolic 
control). The data were taken at one point in time, from three health board areas, NHS 
Tayside, Forth Valley and Fife (members of the diabetes managed clinical network, 
Diabnet). 
 
The study was approved by NHS Forth Valley and Fife Joint Research Ethics 
Committee (Appendix 1), and then by the Multi-centre Research and Development 
Committee (MRAD; Appendix 2). Caldicott Guardian approval was also granted for 
each of the three health boards (Appendix 3a, b & c). 
2.2 Participants 
2.2.1 Selection criteria 
Following ethical and research and development approval, patients diagnosed with type 
1 diabetes within the three paediatric diabetes teams were identified as potential 
participants (ethical considerations are outlined later in the section). The local diabetes 
specialist nurses identified all potential participants, namely adolescents who attend their 
local diabetes team for regular and routine reviews regarding their diabetes care. All 
adolescents who had been diagnosed with type 1 diabetes mellitus for more than 24 
months from NHS Tayside, Forth Valley and Fife were invited to participate in the 
research. A letter informing the adolescents of the research was sent to each patient prior 




information for the chief investigator in case of query or discussion regarding the 
research (Appendix 4a). 
 
All participants were between 13 and 18 years of age. In all cases, informed consent to 
participate in the study was obtained from the participants.  Parental approval for their 
child’s participation was obtained, but was not a necessity as per Section 2(4) of the Age 
of Legal Capacity (Scotland) Act 1991 which states that “A person under the age of 16 
years shall have legal capacity to consent on his own behalf….where, in the opinion of a 
qualified medical practitioner attending him, he is capable of understanding the nature 
and possible consequences of the procedure or treatment.” The Children (Scotland) Act 
1995 also states that parental consent is required for children aged under 16 only if 
research involves a clinical trial of a medicinal product. Therefore the present study did 
not require parental consent if the young person had capacity to consent. Capacity to 
consent was assessed by both the diabetes specialist nurses and the chief investigator 
prior to participation. 
 
Diabnet covers a large geographical area encompassing the three health board areas of 
Tayside, Forth Valley and Fife. These are large rural areas with varied geography and 
several centres of population. They have populations of approximately 390,000, 286,000 
and 350,000, respectively. Within all three areas, patients with either type 1 or type 2 
diabetes are seen by the diabetes services. The Scottish Diabetes Survey 2006 reports the 
statistics of diabetes prevalence by health board in Scotland (Table 1; Scottish Diabetes 
Survey Monitoring Group, 2008). The 2006 report indicated that across Tayside, Forth 
Valley and Fife, approximately 500 adolescents with diabetes are seen collectively 




2.2.2 Inclusion criteria 
• Adolescents (aged 13-18 years inclusively) who have been diagnosed for longer 
than 24 months with type 1 insulin dependent diabetes mellitus.  
 
Individuals with diabetes typically experience a 'honeymoon' phase during the first 12 
months following diagnosis as the pancreas is still producing small amounts of insulin. 
Metabolic control at this time is dependent on the amount of residual pancreatic activity 
and is often under close scrutiny from the diabetes team. It is therefore recommended 
that a 12 month grace period after diagnosis is kept when researching metabolic control 
in this cohort (Shroff Pendley et al., 2002).  
2.2.3 Exclusion criteria 
• Individuals deemed unable to consent as per the Age of Legal Capacity 
(Scotland) Act, 1991 including (a) individuals with an intellectual disability and 
(b) individuals with global impairment due to head injury. 
• Current hypo- or hyperglycaemia (blood glucose below 4 mmol/L or above 20 
mmol/L) at the time of assessment. 
• Individuals with a psychotic illness. 
 
Capacity to consent was required to ensure that the research project was ethically sound 
and all participants were aware of the consequences of their participation. The present 
study required young people to complete a number of self-report questionnaires 
independently, without parental or external assistance. The questionnaires were 
validated only for an adolescent population and no alternative versions of the 
questionnaires were available for those with intellectual impairments. 
 
As cognitive functioning rapidly declines when individuals' blood glucose levels become 




adolescents who were currently in a hypoglycaemic (as defined blood glucose below 
4mmol/L (Cryer, 2002)) or hyperglycaemic (above 20 mmol/L) state were temporarily 
excluded from the study, but permitted to rejoin once their blood glucose levels had 
stabilised. All adolescents test their blood glucose as a matter of routine practice within 
clinic when hypo- or hyperglycaemia is suspected. 
 
Acute mental health difficulties such as psychosis have been found to be strongly 
associated with decreased metabolic control (Lawrence et al., 2006; Nakazato et al., 
2000). Therefore, this group was excluded to reduce confounding variables. 
 
Participation was completely voluntary and participants did not receive any payment for 
their participation. All responses were guaranteed to be anonymous and confidential. 
2.2.4 A priori sample size 
Using a-priori sample size calculation for multiple regression, at the significance alpha 
level of 0.05, a medium anticipated effect size (0.15), a desired statistical power level of 
0.8, for the 11 assessment scales and subscales to be statistically analysed as predictors, 
a sample size of 123 was indicated. 
2.2.5 Sample description 
The present sample included 90 participants (51% male, 49% female), aged 13-18       
(M = 15.8, SD = 1.61) derived from paediatric diabetes clinics across Tayside, Forth 
Valley and Fife health boards. The participant flow through the study is described in 
Figure 2. 
 
During the data collection period, 124 patients were identified as eligible by the diabetes 
specialist nurses using the exclusion/inclusion criteria. Two patients did not consent to 
participation, both stating time constraints as the reason. Eighteen (15%) of the eligible 




give consent or participate in the study. Fourteen (11%) gave consent and started the 
study, but withdrew from the study when they were unable to complete the 
questionnaires during the clinic due to time constraints. These patients were not 
followed up as this would have contravened the protocol agreed by the Ethical 
committee. In total, 90 participants consented to the study and completed the 
questionnaires.  
 
Figure 2: Patient's progress through the study from identification of eligibility to participation. 
 
2.3 Procedure 
All eligible participants and their parents/guardians were sent a letter of invitation 
(Appendix 4a), a young person’s information sheet (Appendix 4b), a parent’s 
information sheet (Appendix 4c) and a consent form (Appendix 4d) at least one week 
prior to their routine diabetes review appointment. All participants were asked to 
2 refused consent 
124 Eligible patients 
104 patients consented 
and were given 
questionnaires 
14 withdrew from the 
study and were therefore 
excluded 
90 completed study 





undergo the same assessment procedure, consisting of a number of questionnaires and 
agreement for the chief investigator to obtain the results of a routine blood test (HbA1c). 
The chief investigator was present at the clinics to describe and explain the research and 
to answer any queries or questions. A thorough briefing was available to all participants 
before and after participation if required. 
 
The diabetes teams involved in this study review their adolescent population within 
clinic every 3-4 months, therefore data collection took place over a 4-month period to 
reduce the chance of participants being approached more than once and increase the 
efficiency of data collection.  
 
The completed consent form was placed in the participant’s medical file and two copies 
were made (one for the patient and one for the chief investigator). To reduce 
inconvenience to participants, the study was held during routine diabetes clinics where 
patients must often wait between consultations with the nurses, consultants and 
dieticians.  
 
The questionnaires were completed in the waiting areas of each diabetes clinic. Some 
participants attended this appointment on their own, although the majority were 
accompanied by parents/guardians or significant others. It was emphasised to those 
accompanying the individual that they should not, at any time, assist the participant 
during the assessment. The participants were encouraged to sit away from their carers if 
it was less distracting. 
 
The participants were asked to complete four questionnaires. These explored family and 
peer diabetes-specific support, (DSSQ- Family and Friends Versions; Bearman & La 
Greca, 2002; La Greca & Bearman, 2002), mood (Hospital Anxiety and Depression 




Module; Varni et al., 2003). In addition, demographic data was collected including age, 
length of diagnosis, method of insulin delivery (injection or pump), gender and location 
of diabetes clinic (Appendix 5). The assessment took approximately 25 minutes to 
complete. 
2.4 Measures 
All measures used within the study were standardised, reliable, valid and widely used 
(Bjelland et al., 2002; Hanna, 2006; Varni et al., 2003). The measures administered fell 
into three basic categories: (a) diabetes-specific social support, (b) quality of life and (c) 
mood, and are summarised in Table 2: 
Table 2:  
Summary of Assessment Measures 
Area Assessed 
 
Assessment Used Source 
Diabetes-specific 
family support 




DSSQ – Friend Version (Bearman & La Greca, 
2002) 
Quality of life PedsQL – Diabetes Module 3.0 (Varni et al., 2003) 
Mood Hospital Anxiety and 
Depression Scale 
(Zigmond & Snaith, 1983) 
   
 
A description of each assessment and information regarding reliability and validity is 
provided below. 
2.4.1 Diabetes-specific social support  
The Diabetes Social Support Questionnaire − Family Version (Appendix 6; La Greca & 
Bearman, 2002) is a specific 58-item Likert scale questionnaire that identifies 




blood glucose monitoring, diet, exercise and emotional support. The scale was 
developed for 11−18 year olds and has been used and found to be reliable and valid 
within the adolescent diabetes population (Hanna, 2006; La Greca & Bearman, 2002). 
The internal consistency reliabilities ranged from .75 to .95 (Hanna, 2006). Both face 
and content validity are evident within the scale upon inspection of the items. The 
DSSQ-Family was developed from the DSSI (Hanna, 2006; La Greca et al., 1995), 
which also has strong predictive and construct validity (La Greca et al., 1995). The 
questionnaire is reported to be more advantageous than the structured interview for 
paediatric research due to its simplified scoring and reduced time required for 
administration (La Greca & Bearman, 2002). 
 
The measure was scored in accordance with the test manual. The frequency of 
supportive behaviours (e.g. “how often does your family…”) were summed, with each 
item ranging from a score of 0 to 5 (high scores indicate greater frequency of the 
reported behaviour). A total for each of the subscales can therefore be calculated: 
 insulin management (ranging from 0 - 50) 
 blood glucose monitoring (0 - 70)  
 diet (0 - 100) 
 exercise (0 - 45) 
 emotional support (0 - 25)  
 
Developed in parallel with the DSSQ-Family, the DSSQ−Friends Version (Bearman & 
La Greca, 2002) is a specific 27-item Likert scale questionnaire that also identifies the 
frequency of support behaviours in terms of insulin management, blood glucose 
monitoring, diet, exercise and emotional support for adolescents with diabetes 
(Appendix 7; Hanna, 2006). The items of the questionnaire are based upon the DSSQ-
Family. Item selection for the DSSQ-Friends was based on data collected from a cohort 




Following data analysis, the DSSQ-Friends was developed with 31 of the original 58 
items eliminated as they were found to be irrelevant for peer support of diabetes care. 
These items were generally perceived as neutral or negative in support, and were rated 
as very low in frequency (Bearman & La Greca, 2002). 
 
The measure was scored as per the test manual, using identical methodology to that used 
for the DSSQ-Family (see above). This enabled a score for each subscale to be 
calculated: 
 insulin management (ranging from 0 - 10) 
 blood glucose monitoring (0 - 30) 
 diet (0 - 65) 
 exercise (0 - 20)  
 emotional support (0 - 15) 
2.4.2 Quality of life 
Quality of life has been increasingly recognised as an important factor in outcome 
assessment of individuals with diabetes since the Diabetes Control and Complications 
Trial (1994). From the DCCT, the first diabetes-specific quality of life measure for 
adolescents was developed, which has since been revised and reviewed (Ingersoll & 
Marrero, 1991). To date, there are several scales available and validated to measure 
quality of life in diabetes populations. Research has indicated that diabetes-specific 
scales are more sensitive to change in this population than general scales (Jacobson et 
al., 1994; Polonksy, 2000) therefore the current study uses the PedsQL-3.0 Diabetes 
module, using both adolescent and diabetes–specific items to assess quality of life. 
 
The PedsQL- 3.0 diabetes module (Appendix 8; Varni et al., 2003) is a specific 27-item 
Likert scale questionnaire for 13-18 year olds with type 1 diabetes that identifies five 




(6 items), worry (3 items) and communication (3 items). Each item is scored depending 
on how frequently the item has been a problem over the last month. The scores for each 
subscale range from 0 (never) to 4 (almost always), leading to a total score between 0 
and 108. 
 
This is a reliable and valid measure of quality of life for adolescents with type 1 diabetes 
based upon a sample size of 147 adolescents (Varni et al., 2003; Varni et al., 2005). 
Adolescent self-report of the diabetes module exceeded the reliability standard of .70, 
with Cronbach alpha’s ranging from .81 to .77 (Nunnally & Bernstein, 1994; Varni et 
al., 2003). 
2.4.3 Mood 
The Hospital Anxiety and Depression Scale (Appendix 9; Zigmond & Snaith, 1983) is a 
widely used measure to assess depressive symptomology in health care settings and has 
been shown to be reliable and valid in both adult (α = .76) and adolescent (α = .74) 
populations (Mykletun et al., 2001; White et al., 1999). The HADS has been used 
widely in studies with several aspects of disease and quality of life. A main 
characteristic of
 
HADS is that items covering somatic symptoms of depression
 
have 
been eliminated to avoid false-positive results when used
 
with diabetes populations 
(Engum et al., 2005). It is also sensitive to change during the course of disease (Shaban, 
2003) and has therefore been shown to be an appropriate measure of mood disturbance 
for use in a diabetes clinic setting (Lloyd et al., 2000). The total possible score for the 
depression subscale is 21.  
 
White and colleagues (1999) validated the HADS for an adolescent population and 
recommend that a score of 0-6 should be considered ‘normal’, 7-9 should indicate 
‘possible depression’ and 10+ should indicate ‘probable depression’ to minimise the risk 




2.4.4 Metabolic control 
Metabolic control is also referred to within research literature as ‘diabetes control’, 
‘glucose control’, and ‘glycaemic control’ (Goldstein et al., 2004). This study will 
follow the terminologies used within the DCCT, which uses language widely accepted 
and replicated in international diabetes research. The DCCT established specific diabetes 
treatment goals using the HbA1c blood test. It is therefore used as the ‘gold standard’ of 
metabolic control and is routinely used throughout all diabetes clinics in the UK and 
USA (Goldstein et al., 2004; DCCT, 1993; DCCT, 1994).  
 
The HbA1c provides a value (reported as a percentage value) indicating the average 
blood glucose levels over the previous three months. The NICE Guidelines (Clinical 
Guideline 15) and SIGN (Guideline 55) (NICE, 2004; Scottish Intercollegiate 
Guidelines Network, 2001) have supported the DCCT guidelines for a target HbA1c 
value of less than 7.5% to prevent future complications. HbA1c values of over 9% are 
considered to indicate ‘poor metabolic control’.  
2.5 Ethical considerations 
The Joint Research Committee of NHS Fife and Forth Valley passed this study for 
multi-site inclusion (all three health boards) in January 2008. The Multi-centre research 
and development committee passed the study in March 2008. Some of the key ethical 
issues considered in this research are outlined below. 
2.5.1 Participant confidentiality 
To ensure response anonymity and confidentiality, each consenting participant was 
assigned a number used to identify their completed questionnaires and HbA1c results 
thereafter. These data were collected from March 2008 until the end of June 2008. The 




filing cabinet on NHS property. The list of identification numbers and participation 
consent forms will be kept for five years in a locked cabinet within NHS property. 
 
Data were entered into a statistical package on a password-protected NHS computer. No 
patient details (e.g. CHI, name) were collected. The computer data will be held for a 
minimum period of five years in line with the research guidelines (Singleton & 
Wadsworth, 2006) and will be the responsibility of the chief investigator. 
2.5.2 Distress during assessment 
It was not anticipated that this study would cause any distress to participants. The 
questionnaires are routinely used in clinical practice and in research and there are no 
findings to suggest that completion leads to an elevation in negative mood or distress. 
All the questionnaires have been administered to adolescents with diabetes previously 
with no noted adverse effects (Hains et al., 2007; Laffel et al., 2003; Lewandowski & 
Drotar, 2007; Miller & Drotar, 2007; Sudhir et al., 2003). Opportunities to discuss 
psychological support issues may be beneficial to the young person, allowing time for 
reflection (Surkan et al., 2008). The measures selected are standardised and are routinely 
used in clinical practice and research. Shortened versions of the questionnaires were 
used where possible, to avoid prolonged completion time.  
 
Completion of the questionnaires in a setting with clinician and health professional 
support ensured that, in the unlikely event of distress occurring, such distress could be 
promptly addressed. The chief investigator was also available throughout if further 
support was required. All participants were already under the care of the diabetes teams, 
which each have Clinical Psychology support and a referral would have been made 
should any further input have been required. Participants were informed that they were 
under no obligation to participate and could withdraw at any point, without their care 




2.5.3 Capacity issues 
It was foreseen that there may be issues relating to an individual’s capacity to consent to 
participate in this research. It was therefore agreed that if there were any doubt (by the 
chief investigator) regarding an individual’s ability to consent, they would be excluded 
as per Section 2(4) of the Age of Legal Capacity (Scotland) Act 1991 and Adults with 
Incapacity (Scotland) Act 2000. 
2.5.4 Other ethical issues 
It was possible that the assessment might reveal previously undetected psychological 
dysfunction, for example clinically significant levels of depression. If any participant 
scored within the ‘probable depression’ range, it was agreed that the chief investigator 
would discuss with the adolescent about sharing this information with the diabetes team, 
considering both duty of care and the participant’s right to confidentiality.  
2.6 Data analysis 
The data were entered onto a spreadsheet and all statistical analyses were run using the 
Statistical Package for the Social Sciences (SPSS) for Windows, Version 12.0. The data 
were examined for normality, homoscedasticity and linearity. Questionnaires with more 
than 5% of missing data were excluded from the analysis following the test scoring 
guidelines: (Bearman & La Greca, 2002; La Greca & Bearman, 2002; Varni et al., 2003; 
Zigmond & Snaith, 1983). When less than 5% of data were missing from the 
questionnaires, means were calculated from the available data and used to estimate the 
missing values prior to analysis (using the ‘means substitution’ function of SPSS). This 
is the most conservative method of estimating missing values, as the means for the 
distribution as a whole do not change. Demographic and clinical characteristics of the 
participants including age, mood and insulin management regimen (pump use or 
injections) were further examined to identify how far these variables might explain any 





Pearson correlation coefficients were calculated to examine the links between the 
participant’s scores from the social support measures (DSSQ), metabolic control 
(HbA1c) and diabetes-related quality of life (PedsQL) scores. The differences between 
the frequency of support given by family and peers were examined using t-tests. 
Standard multiple regression analysis was then carried out to examine the relationship 
between social support and metabolic control, and between social support and diabetes-
related quality of life. All post hoc analyses and effect size calculations were performed 
using G*Power Version 3.0. 
 
   
 64 
3 Results 
3.1 Participant characteristics 
3.1.1 Demographic characteristics 
Demographic and clinical data are summarised in Table 3. The participants’ average age 
was 15 years, with an average length of diagnosis of 6 years. In the total sample, 46 
participants were male (51%) and 44 were female (49%). 
 
Table 3:  
Demographic Characteristics: The Age and Length of Diagnosis of Participants  
 Mean (SD) Range  
Age in years 15.87 (1.59) 13.0-18.8 
 
Length of 





N = 90   
 
Table 4 provides a summary of the frequency of participants recruited from each of the 
diabetes clinics involved in the study. Most participants were seen at the city clinics 
(Dundee, Stirling, Kirkcaldy and Perth). The remaining participants were seen at the 
satellite clinics in Arbroath and Montrose.  
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Table 4:  
Demographic Characteristics: The Distribution of Clinics Attended by Participants 
  Frequency Percentage of 
total sample 
Clinic Attended Fife: Kirkcaldy 17 18.9 
 Forth Valley: Stirling 17 18.9 
 Tayside: Dundee 32 35.6 
 Tayside: Perth 12 13.3 
 Tayside: Arbroath 8 8.9 
 Tayside: Montrose 4 4.4 
N = 90    
 
3.1.2 Clinical characteristics 
Within the current sample, 11 of the 90 participants (12%) used an insulin pump to 
deliver their insulin treatment; the remaining 79 used injections. The average HbA1c for 
the sample was 9.73% (SD = 1.73). This is classified as ‘poor’ metabolic control and is 
significantly higher than the international recommendation of 7.5% (t (89) = 12.21,         
p < 0.001). 
 
Within an adolescent population, a HADS Depression score of 7 - 9 is indicative of 
‘possible depression’ (White et al., 1999). Seven of the 90 participants (8%) scored 
within this range. None of the participants scored 10 or more (indicative of ‘probable 
depression’) on the subscale. The mean HADS depression score was 2.47 (SD = 2.30). 
3.2 Preliminary analysis 
All data were analysed to identify whether the assumptions of normality, linearity and 
homoscedasticity had been violated.  
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3.2.1 HADS: Depression data 
The kurtosis values, and visual inspection of the data indicated that the HADS: 
Depression subscale data did not violate assumptions of homoscedasticity or linearity. 
However, the data was positively skewed. Following visual inspection of the data, the 
Kolmogorov-Smirnov (p < .001) and Shapiro-Wilk (p < .001) statistics were performed, 
and these revealed that the HADS Depression data were not normally distributed. 
Therefore, a square root transformation was used and the transformed skewness and 
kurtosis data are shown in Table 5. Following transformation, parametric statistics were 
used for data analysis.  
 
Table 5:  
Preliminary Data Analysis of HADS: Depression Data including Skewness and Kurtosis values prior to 
and post-transformation 
 
According to previous research, the HADS Depression subscale has good internal 
consistency, with Cronbach alpha coefficients reported to be .76 (Mykletun et al., 2001). 
In the current study, the alpha coefficient was found to be .56. 
3.2.2 HbA1c data 
The skewness and kurtosis values, and visual inspection of the data indicated that the 
HbA1c data did not notably violate assumptions of homoscedasticity, linearity or 

























0-3 -.18 (0.25) -0.97 
(0.50) 
 
N = 90       
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normality (Table 6) and therefore parametric statistics could be performed without the 
need for transformation of the data. 
 
Table 6:  
Preliminary Data Analysis of HbA1c Data including Skewness and Kurtosis values 






9.73 (1.73) 6.50-13.73 0.52 (0.25) -0.36 (0.50) 
N = 90     
 
3.2.3 Psychometric information for the self report measures 
Psychometric information for the social support and diabetes related quality of life self-
report measures is summarised in Table 7. Distributions of all subscales (with the 
exception of DSSQ-Friends Insulin management and diet, and DSSQ-Family Emotion 
subscales) were positively skewed, however, visual inspection of the data indicated that 
the distributions fell within acceptable ranges for both skewness and kurtosis 
(Tabachnick & Fidell, 2007). Therefore the data did not seriously deviate from 
normality and parametric statistics were used without the need for data transformation. 
Visual inspection of the data revealed that there were no outliers for any of the variables. 
 
According to Bearman & La Greca (2002), the DSSQ-Friends subscales have good to 
excellent internal consistency, with Cronbach alpha coefficients reported between .58 
(insulin management) to .89 (meals). In the current study, the alpha coefficient was 
ranged from .47 (insulin management) to .92 (diet). The smaller alpha reported for 
insulin management subscales may be partly explained by the small number of items 
within the subscale (two). However the internal consistency reported within the current 
study suggests that the individual subscales may be used reliably within the analysis. 
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Likewise, La Greca & Bearman (2002) found the internal consistency of DSSQ-Family 
subscales to be good to excellent with Cronbach alphas reported between .75 (insulin 
management) and .93 (diet). In the current study, the Cronbach alphas were found to 
range between .84 (insulin management) and .94 (diet). Therefore the subscales may be 
used individually within the present study.  
 
Finally, the PedsQL scale was also found to have good internal consistency with a 
Cronbach alpha coefficient of .82. A previous study reported alpha values ranging from 
.63 to .81 (Varni et al., 2003). 
Table 7:  
Psychometric Description of Self-reported Social Support and Quality of Life measures 
Measure Subscale Mean 
(SD) 








0-10 0.61  
 
-0.60  .47 




0-30 0.49  
 
-0.84  .85 
 Diet 24.02 
(17.20) 
0-65 0.56  
 
-0.67  .92 
 Exercise 8.77 
(5.54) 
0-20 0.10  
 
-0.96  .75 
 Emotion 7.49 
(5.18) 





0-50 0.14  
 
-0.61  .84 




6-70 0.39  
 
-0.18  .89 
 Diet 60.70 
(24.38) 
8-99 -0.39  -0.78  .94 
 Exercise 15.69 
(12.51) 
0-45 0.57  
 
-0.63  .91 
 Emotion 16.30 
(7.07) 






10-80 0.45  
 
-0.59  .82 
N = 90    *Standard 









To examine the relationships between the variables, Pearson’s correlation coefficients 
were calculated (Table 8). HbA1c was found to be negatively correlated with the 
frequency of support given by peers for blood glucose monitoring (r = -.22). Higher 
levels of support given for blood glucose monitoring were associated with lower HbA1c 
(better metabolic control). 
 
PedsQL scores were found to be negatively correlated with the frequency of emotional 
support given by their family (r = -.26). Higher levels of emotional support were 
associated with lower PedsQL scores (better diabetes-specific quality of life). 
 
Finally, the subscales of the DSSQ Friends and Family measures were all highly 
correlated, indicating that high levels of support given by family were associated with 
high levels of support given by peers. The only exception was that the association 
between levels of support given by family for exercise and levels of emotional support 
provided by peers was marginally non significant (r = .21). 
 
   
 
 
Table 8: Pearson Correlations (r) for Measures of Social Support, Mood (HADS), Metabolic Control (HbA1c) and Diabetes-Related Quality of Life (PedsQL) 

































Age Pearsons’(r ) 1              
  Sig (p)                









            
  p .744               
  N 89 89             
Blood Glucose Monitoring r .012 .665** 1            
  p .910 <.001              
  N 89 89 89            
Diet r .092 .577** .679** 1           
  p .396 <.001 <.001             
  N 88 88 88 88           
Exercise r -.179 .387** .438** .496** 1          
  p .096 <.001 <.001 <.001            
  N 87 87 87 87 87          
Emotion r .132 .571** .617** .544** .227* 1         
  p .224 <.001 <.001 <.001 .035           



















       
  p .032 .001 .001 <.001 <.001 .001          
  N 88 87 87 86 85 85 88        
Blood Glucose Management r -.221* .360** .378** .408** .399** .244* .799** 1       
  p .039 .001 <.001 <.001 <.001 .024 <.001         
  N 88 87 87 86 86 86 87 88       
Diet r -.153 .361** .390** .480** .480** .334** .644** .668** 1      
  p .150 .001 <.001 <.001 <.001 .002 <.001 <.001        
 N 90 89 89 88 87 87 88 88 90      
Exercise r -.255* .294** .253* .356** .467** .208 .473** .473** .604** 1     
  p .016 .005 .017 .001 <.001 .054 <.001 <.001 <.001       
  N 89 88 88 87 86 86 87 87 89 89     
Emotion r -.157 .379** .440** .358** .289** .437** .472** .525** .643** .664** 1    
  p .144 <.001 <.001 .001 .007 <.001 <.001 <.001 <.001 <.001      
  N 88 87 87 86 85 85 87 86 88 88 88    
HADS- Depression  r -.039 -.128 -.109 -.091 -.218* -.119 .207 .155 .008 .054 -.056 1   
 (transformed) p .718 .233 .309 .398 .042 .272 .053 .149 .938 .617 .601     
  N 90 89 89 88 87 87 88 88 90 89 88 90   
PedsQL r -.016 .061 -.086 -.033 -.206 -.074 .212 .148 .026 -.080 -.255* .610** 1  
  p .880 .576 .434 .764 .062 .509 .053 .179 .811 .466 .019 <.001    
  N 86 85 85 84 83 83 84 84 86 85 84 86 86  
HbA1c r .025 .022 -.217* -.059 -.106 -.072 .115 .083 -.019 -.179 -.110 .312** .301** 1 
  p .812 .841 .041 .587 .328 .505 .288 .442 .862 .092 .307 .003 .005   








3.4 Missing data 
The distribution of missing data is indicated in Table 9. There was no consistent pattern 
to the missing data. 
 
Table 9:  
Distribution and Quantity of Missing Data 





















PedsQL Diabetes module 3 
HbA1c 0 
  
3.5 Potential confounding variables 
Previous research has highlighted the potential impact of age, mood and insulin pump 
use when considering relationships between social support, metabolic control and 
diabetes-related quality of life. For this reason, the data were further examined to assess 
how far the outcome variables (metabolic control and diabetes-related quality of life) 
could be explained by age, mood and pump use. Only relationships found to be 
significant by the Pearson’s correlations calculations were further examined to identify if 





3.5.1 The potential impact of age 
Age and metabolic control 
Only the frequency of support for blood glucose monitoring by peers was found to be 
significantly correlated to metabolic control.  
 
Partial correlation was used to explore the relationships between peers’ support for 
blood glucose monitoring and metabolic control, whilst controlling for age. When age 
had been controlled for, the correlation between peers’ support for blood glucose 
monitoring and metabolic control (HbA1c) remained significant (r = -.22, N = 90,          
p = .04). An inspection of the zero order correlation (r = -.22) suggested that controlling 
for age had a negligible effect on the strength of the relationship between these two 
variables.  
Age and diabetes-specific quality of life 
Family emotional support was the only independent variable to be significantly 
correlated with diabetes-related quality of life (PedsQL). Partial correlation was used to 
further explore the relationship between family emotional support and diabetes-related 
quality of life, whilst controlling for age. When age had been controlled for, the 
correlation between family emotional support and diabetes-related quality of life 
remained significant (r = -.26, N = 90, p = .02). An inspection of the zero order 
correlation (r = -.26) suggested that controlling for age had a negligible effect on the 





3.5.2 The potential impact of mood 
Mood and metabolic control 
The relationship between mood (as measured by the HADS depression subscale) and 
metabolic control (as measured by the HbA1c), was investigated using Pearson product-
moment correlation coefficient. The transformed HADS depression data were used to 
ensure no violation of the assumptions of normality, linearity and homoscedasticity.  
 
Partial correlation was used to explore the relationship between peers’ support for blood 
glucose monitoring and metabolic control whilst controlling for low mood. When mood 
had been controlled for, the relationship between peers’ support for blood glucose 
monitoring and metabolic control was no longer significant (r = -.19, N = 90, p = .08). 
An inspection of the zero order correlation (r = -.22) suggested that controlling for mood 
had a small effect on the strength of the relationship between these two variables.  
Mood and diabetes-related quality of life 
Partial correlation was used to identify the extent to which the relationship between 
social support and diabetes-related quality of life scores might be explained by mood. 
When mood was controlled for, the relationship between family emotional support and 
diabetes-related quality of life remained significant (r = -.28, N = 90, p = .01). An 
inspection of the zero order correlation (r = -.26) suggested that controlling for mood 
had a small effect on the strength of the relationship between these two variables.  
Implications for data analysis 
As age appeared to have a negligible effect on the relationships between the independent 
variables (social support) and dependent variables (HbA1c values and PedsQL scores), it 





Therefore, age was not included as an independent variable within the subsequent 
regression analyses. 
 
However, mood had a small but significant effect on the relationship between the 
independent variables (social support) and dependent variables (HbA1c and PedsQL) so 
was included within subsequent regression analyses as a potential predictor. 
3.5.3 Examining the effect of insulin management regimens 
The data were split according to those participants who used an insulin pump compared 
with those who injected insulin. 
Metabolic control and insulin management regimens 
An independent samples t-test was conducted to compare the HbA1c values for two 
different forms of insulin management regimens, namely pump use and injections. There 
was no significant difference in HbA1c values for pump users (M = 9.53, SD = 1.43), 
and participants who injected their insulin (M = 9.75, SD = 1.77) t (88) = .40, p = .69.  
 
The magnitude of the differences in the means (effect size) was extremely small             
(d = -.09). 
Diabetes-related quality of life and insulin management regimens 
An independent samples t-test was also used to compare the PedsQL scores for 
participants using an insulin pump and those who use injections. There was no 
significant difference in PedsQL scores for pump users (M = 30.60, SD = 10.91), and 
those using injections (M = 37.89, SD = 18.96), t (17.26) = 1.79, p = .09.  
 





Implications for data analysis 
As pump use appeared to have very little effect on the dependent variables (HbA1c 
values and PedsQL scores), it is unlikely that this clinical characteristic will account for 
significant variance in the dependent variables.  
3.6 Hypothesis 1 
 Support for ‘practical diabetes management tasks’ (insulin injections, blood 
glucose monitoring and diet) will be provided more frequently by family than by 
peers. 
 
The DSSQ Friends and Family questionnaires are reported to be comparable in research 
and clinic settings (Bearman & La Greca, 2002). The friends version has fewer items 
than the family version that were removed during the scale’s development to ensure 
reliability and validity (Bearman & La Greca, 2002). Support for insulin management, 
blood glucose monitoring and diet are rated as individual subscales of the questionnaire. 
As each subscale has a different number of items, to compare the frequency of support 
given by both family and peers, it was necessary to calculate a scaled or ‘percentage’ 
score of the total possible frequency of each subscale. Therefore, for each subscale, the 
score that identifies the frequency of support reported by each participant was divided by 
the total possible frequency score. This provided a scaled score that could be compared 
within the analysis. 
 
A paired samples t-test was conducted to examine the differences between the total 
frequency of support for all ‘practical diabetes management tasks’ (insulin management, 
blood glucose monitoring and diet) by family and peers. Family (M = 52.41,                 





tasks’ than peers (M = 37.26, SD = 24.72), t (84) = 6.34, p < .001. The magnitude of the 
differences in the means revealed a large effect size (d = 0.98). 
3.6.1 Hypothesis 1a 
 Support for insulin injections will be provided more frequently by family than 
peers. 
 
A paired samples t-test was conducted to examine the differences between the frequency 
of support for insulin management by family and peers. Family (M = 46.92, SD = 24.29) 
provided significantly more support for insulin management than peers (M = 31.72, SD 
= 27.54), t (86) = 4.79, p < .001. The magnitude of the differences in the means revealed 
a moderate effect size (d = 0.73).  
3.6.2 Hypothesis 1b 
 Support for blood glucose monitoring will be provided more frequently by 
family than peers. 
 
The difference between the amount of support given by family and peers for blood 
glucose monitoring was examined using a paired-samples t-test. A significant difference 
was found between the relative frequency of support given by family    (M = 46.91, SD 
= 21.51) and peers (M = 40.50, SD = 29.15), t (79) = 2.01, p = .048). Family therefore 
provided more support for blood glucose monitoring than peers. The magnitude of the 








3.6.3 Hypothesis 1c 
 Support for diet will be provided more frequently by family than peers. 
 
Following analysis using a paired-samples t-test, a significant difference was found 
between the frequency of support provided for diet by family (M = 46.57,              SD = 
21.17) and peers (M = 39.89, SD = 29.08; t (86) = 2.17, p = .03). Family therefore 
provided more support for diet than peers. The magnitude of the difference in the means 
(d = 0.37) indicated a small effect size. 
3.7 Hypothesis 2 
 ‘Companionship’-related support (emotional support and support for exercise) 
will be provided more frequently by peers than family. 
 
A paired samples t-test was conducted to examine the differences between the total 
frequency of ‘companionship’-related support (emotional support and support for 
exercise) given by family and peers. There was no significant difference between the 
frequency of ‘companionship’-related support (exercise and emotional support) given by 
family (M = 45.44, SD = 25.33) or peers (M = 46.44, SD = 24.29), t (82) = 0.36,  p = 
.72). The magnitude of the differences in the means (d = -0.06) indicated a very small 
effect size. 
3.7.1 Hypothesis 2a 
 Emotional support will be provided more frequently by peers than family. 
 
The data were split to analyse the difference between the frequency of support given by 






A paired-samples t-test was used to identify any significant differences between the 
mean frequency of emotional support (as measured by the emotions subscale of the 
DSSQ) given by family and peers to adolescents with diabetes. Family (M = 65.25,      
SD = 28.24) provided significantly more emotional support than peers (M = 49.24,      
SD = 34.72), t (82) = 4.29, p = <.001). The magnitude of the differences in the means             
(d = 0.67) indicated a moderate effect size. 
3.7.2 Hypothesis 2b 
 Support for exercise will be provided more frequently by peers than family. 
 
Likewise, the frequency of support for exercise was analysed separately. A paired-
samples t-test was also used to identify any significant differences between the mean 
frequency of support for exercise given by family and peers. In this study, peers           
(M = 44.41, SD = 27.99) provided significantly more support for exercise than family 
(M = 34.50, SD = 27.04; t (83) = 3.17, p = .002). The magnitude of the differences in the 
means (d = 0.49) indicated a small to moderate effect size.  
3.8 Hypothesis 3 
 Family support for practical diabetes management tasks (blood glucose 
monitoring, insulin management and diet) will be more predictive of metabolic 
control than (a) peer support for practical diabetes management tasks (blood 
glucose monitoring, insulin management and diet), (b) family compassionate  
support (emotional support and support for exercise), or (c) peer compassionate 
support (support for emotions and exercise). 
 
Pearson r correlations were calculated (Table 10) between the diabetes social support 





Table 10:  
Pearson r correlations between diabetes related social support (DSSQ), metabolic control (HbA1c) and 
quality of life (PedsQL) 
















HbA1c Pearson r 1      
  Sig       
  N 90      
PedsQL r .301** 1     
  Sig .005      
  N 86 86     
Peer Diabetes Management 









   
(Insulin, blood glucose 
monitoring and diet) 
Sig .305 .689     
  N 88 84 88    
Family Diabetes 












(Insulin, blood glucose 
monitoring and diet) 
Sig .704 .288 <.001    
















 (exercise and emotions) Sig .291 .103 <.001 <.001   

















 (exercise and emotions) Sig .116 .156 <.001 <.001 <.001  
 N 88 84 86 86 85 88 
 **   significant at the  0.01 level (2-tailed). 
DMT = Diabetes Management Tasks 
Comp = Compassionate 
 
Fishers Z transformations were used to compare the correlation coefficients identified 
within Table 10 using the techniques of Meng et al., (1992). The Z scores and 







Table 11:  
Correlation coefficient comparisons of the relationships between Diabetes related social support and 
HbA1c 
Diabetes related social supports compared in analysis with 
HbA1c 
N Z p 
(one tailed) 
Family Diabetes Management Task support and Peer Diabetes 
Management Task support 
85 .674 .250 
Family Diabetes Management Task support and Peer 
compassionate support 
85 .717 .237 
Family Diabetes Management Task support and Family 
compassionate support 
86 1.437 .075 
Peer Diabetes Management Task support and Peer 
compassionate support 
87 .050 .480 
Peer Diabetes Management Task support and Family 
compassionate support 
86 .504 .307 
Peer compassionate support and Family compassionate 
support 
85 .498 .309 
* significant at the 0.05 level    
 
None of the correlation coefficients between types of diabetes related support were 
found to be statistically significantly different.  Additionally, using the test for contrast 
among multiple correlated correlation coefficients (Meng et al., 1992), family support 
for diabetes management tasks did not have a significantly higher correlation coefficient 
with HbA1c as predicted (Z = 1.07, p > .05).  
 
A forced entry hierarchical multiple regression was performed between metabolic 
control (HbA1c; the criterion variable) and the frequency of diabetes-specific social 
support provided by both family and peers (the DSSQ; the predictor variables). As mood 
was found to have a small effect on the relationship between some of the independent 
variables and HbA1c, this was included as a potential predictor. Analysis was performed 
using SPSS Regression and SPSS Explore for evaluation of assumptions. Family 





the first block of the regression analysis. All other variables were added to the second 
block using the stepwise method as described by Field (2000). 
 
Preliminary analyses were performed to ensure no violations of the assumptions of 
normality, linearity and homoscedasticity (see Appendix 10). With the use of p < .001 
criterion for Mahalanobis distance, no outliers among the cases were found. Missing 
data were replaced using SPSS ‘mean substitution’, which is considered to be a 
conservative method (Tabachnick & Fidell, 2007). 
 
Table 12 displays the unstandardised regression coefficients (B), constant (intercept), the 






 change for each step of the 





Table 12:  
Hierarchical Multiple Regression of Social Support given by Family and Peers on Metabolic Control (HbA1c) 
Variables entered Unstandardised 
B 






 Adjusted R 
2
 ∆ R2 
STEP 1: Constant 9.63 .52  .029 -.007 .029 
DSSQ Family  
Insulin Management 
.03 .03 .18    
Blood glucose monitoring .006 .02 .05    
Diet -.012 .01 -.17    
STEP 2: Constant 8.99 .56  .107 .061 .078 
DSSQ Family  
Insulin Management 
.02 .03 .11    
Blood glucose monitoring .001 .02 .01    
Diet -.007 .01 -.09    
HADS .56 .22 .29*    
STEP 3: Constant 9.18 .55  .158 .104 .052 
DSSQ Family  
Insulin Management 
.03 .03 .17    
Blood glucose monitoring .004 .02 .04    
Diet -.003 .01 -.04    
HADS – Depres (trnsf) .48 .21 .25*    
DSSQ Friends 
Blood Glucose Monitoring 
-.05 .023 -.26*    
STEP 4: Constant 9.00 .55  .207 .145 .049 
DSSQ Family  
Insulin Management 
.03 .03 .19    
Blood glucose monitoring .01 .02 .08    
Diet .007 .01 .09    
HADS – Depres (trnsf) .47 .21 .24*    
DSSQ Friends 
Blood Glucose Monitoring 
-.05 .02 -.26*    
DSSQ Family 
Exercise 
-.04 .019 -.29*    
STEP 5: Constant 8.91 .53  .261 .193 .054 
DSSQ-Family       
Insulin management .026 .024 .181    
Blood glucose monitoring .005 .020 .042    
Meals .008 .011 .114    
Exercise -.045 .018 .319*    
DSSQ-Friends       
Insulin management .205 .087 .330*    
Blood glucose monitoring -.091 .028 .462**    
HADS- Depres (trnsf) .546  .205  .280**    





All ten social support variables were added as predictor variables in the regression. 
Mood (HADS Depression transformed scale) was added to explore if it was a significant 
predictor of metabolic control. Addition of the following variables added no further 
prediction and were excluded from the final regression model using the methods 
outlined as per stepwise regression analysis: peers’ support for diet, peers’ support for 
exercise, peers’ emotional support, family emotional support.  
 
The R coefficient for regression was significantly different from zero at the end of each 
step with the exception of steps 1 and 2. For the final model, R
2 
was .26, F(7,76) = 3.82,            
p = .001. The adjusted R
2
 value was .19 which indicates that approximately 19% of the 
variability in HbA1c was predicted by all social support and mood variables added to the 
regression. 
 
After step 1, with the three family diabetes management task support variables in the 
equation, R
2 
was .029, F(3,80) = .798, p = .498. After step 2, with the square root of 
HADS-Depression added to the three family diabetes management task support 
variables, R
2 
was .107, F(4,79) = 2.357, p = .061.  Mood accounted for an additional 
7.8% of the variance in HbA1c. After step 3, with Peer support for blood glucose 
monitoring added to the equation, R
2 
was .158, F(5,78) = 2.932, p = .018, accounting for 
an additional 5.2% of the variance in HbA1c. After the addition of the variable Family 
support for exercise, R
2 
was .207, F(6,77) = 3.352, p = .005, accounting for an additional 
4.9% of variance in HbA1c. Finally after the addition of the Peers’ support for insulin 
management variable, R
2 
was .261, F(7,76) = 3.82, p = .001, accounting for an 
additional 4.9% of variance in HbA1c. 
 
A number of significant predictors were identified from the variables entered, namely 





(β = .33, p = .022), peers’ support for blood glucose monitoring (β = .462, p < .01) and 
low mood (β = .28, p < .01).  
 
In order to obtain a final regression model which contained only significant predictors, 
the significant predictors identified in the final model (step 5) were re-analysed using 
forced entry method of multiple regression. The unstandardised regression coefficients 
(B), constant (intercept), the standard regression coefficients (β), R
2
, and adjusted R
2 
for 
this model are shown in Table 13. 
 
Table 13:  
Forced Entry Multiple Regression of only significant predictors identified on Metabolic Control (HbA1c) 
 
 Variables entered Unstandardised 
B 
Standard 









Constant 9.494 .418  .230 .193 
DSSQ-Friends      
Insulin management .232 .081 .376**   
Blood glucose monitoring -.075 .026 -.374**   
DSSQ-Family      
Exercise -.030 .014 -.213*   
HADS- Depression (trnsf) .645 .190 .332**   
*p < .05, **p < .01, N = 84 
 
The regression solution is extremely sensitive to the combination of variables that is 
included in it (Tabachnick & Fidell, 2007), therefore whether a predictor appears 
particularly important in a solution depends on the other potential predictors in the set. It 
is not unusual therefore that the standardised β reported in Table 13 for each variable is 






The R coefficient for the regression was significantly different from zero F(4,83) = 
6.193, p < .001. R
2 
was .23. The adjusted R
2
 was .193 indicating approximately 19.3% of 
the variability in HbA1c could be accounted for by levels of social support and mood. 
 
In the final model, the criterion variable (HbA1c) was most strongly impacted by peers’ 
support for insulin management (β = .376, p < .01) followed by peer support for blood 
glucose monitoring (β = -.374, p < .01), mood (β = .332, p < .01) and finally family 
support for exercise (β = -.213, p = .04).  
 
The size and direction of the relationships suggest participants with lower levels of peer 
support for insulin management, higher levels of peer support for blood glucose 
monitoring, increased mood and higher levels of support from family concerning 
exercise will have better metabolic control (lower HbA1c values). The three variables 
for family diabetes management tasks support did not appear to have a significant 
impact on HbA1c as predicted. 
 
Effect size calculations (Cohen’s f 
2
) revealed a large effect size of 0.35 and power       
(1 - β) of .96, which indicates that the analysis was sufficiently powered. Very few 
studies in this field have reported effect size, the effect size of the current study is 
consistent with the work of La Greca et al., (1995), who used similar methodology and 
populations.  
3.9 Hypothesis 4 
 Peer emotional support and support for exercise will be more predictive of 
diabetes-related quality of life than (a) family emotional support and support for 
exercise, and (b) support for practical diabetes management tasks (blood glucose 






Pearson r correlations were calculated (Table 10) between the diabetes social support 
variables, HbA1c (metabolic control) and PedsQL (quality of life). Fishers Z 
transformations were then used to compare the correlation coefficients identified within 
Table 10 using the techniques outline by Meng et al., (1992). The Z scores and 
significance values of the differences calculated between the correlations are reported in 
Table 14. 
 
Table 14:  
Correlation coefficient comparisons of the relationships between Diabetes related social support and 
quality of life (PedsQL) 
Diabetes related social supports compared in analysis with 
PedsQL 
N Z p 
(one tailed) 
Family Diabetes Management Task support and Peer Diabetes 
Management Task support 
85 .746 .228 
Family Diabetes Management Task support and Peer 
compassionate support 
85 -.595 .276 
Family Diabetes Management Task support and Family 
compassionate support 
86 -.425 .335 
Peer Diabetes Management Task support and Peer 
compassionate support 
87 -1.761 .039* 
Peer Diabetes Management Task support and Family 
compassionate support 
86 -.989 .161 
Peer compassionate support and Family compassionate 
support 
85 .832 .416 
* significant at the 0.05 level    
 
Only in comparison with peers’ support for diabetes management tasks was peers’ 
compassionate support was significantly more highly correlated with quality of life. 
Additionally, using the test for contrast among multiple correlated correlation 
coefficients (Meng et al., 1992), peers’ compassionate support was not significantly 






Preliminary analyses were performed to ensure no violations of the assumptions of 
normality, linearity and homoscedasticity (see Appendix 11). With the use of p < .001 
criterion for Mahalanobis distance, no outliers among the cases were found. Missing 
data was replaced using SPSS ‘mean substitution’. Peer compassionate support variables 
were entered using the ‘enter’ method into the first block of the regression analysis. All 
other variables were added to the second block using the stepwise method as described 






Table 15:  
Hierarchical Multiple Regression of Social Support given by Family and Peers on Diabetes-Related 
Quality of Life 
Variables entered Unstandardised 
B 








 ∆ R2  
STEP 1: Constant 41.785 4.442  .040 .015 .040 
DSSQ Friends Exercise -.655 .373 -.202    
Emotion .019 .407 .005    
STEP 2: Constant 23.368 4.670  .367 .342 .327 
DSSQ Friends Exercise -.300 .310 -.092    
Emotion .057 .333 .016    
HADS Depress (trsnf) 11.978 1.910 .583**    
STEP 3: Constant 29.761 5.098  .422 .391 .054 
DSSQ Friends Exercise -.114 .307 -.035    
Emotion .417 .348 .118    
HADS Depress (trsnf) 12.052 1.839 .587**    
DSSQ Family  Emotion -.671 .253 -.266*    
STEP 4: Constant 29.867 4.859  .482 .447 .060 
DSSQ Friends Exercise -.560 .330 -.172    
Emotion .268 .335 .076    
HADS Depress (trsnf) 10.099 1.875 .492**    
DSSQ Family  Emotion -.933 .257 -.370**    
DSSQ Family 
Insulin Management 
.498 .170 .330**    
STEP 5: Constant 30.669 4.769  .511 .471 .029 
DSSQ Friends Exercise -.687 .328 -.211*    
Emotion -.166 .389 -.047    
HADS Depress (trsnf) 10.485 1.844 .510**    
DSSQ Family  Emotion -.971 .252 -.385**    
DSSQ Family 
Insulin Management 
.451 .168 .299**    
DSSQ Friends 
Insulin management 
1.549 .746 .236*    
STEP 6: Constant 28.401 4.808  .537 .492 .026 
DSSQ Friends Exercise -.858 .333 -.264*    
Emotion -.187 .381 -.053    
HADS Depress (trsnf) 10.521 1.807 .512**    
DSSQ Family  Emotion -1.266 .287 -.502**    
DSSQ Family 
Insulin Management 
.323 .176 .214    
DSSQ Friends 
Insulin management 
1.627 .732 .248*    
DSSQ Family         Diet .191 .095 .257*   






Table 15 displays the unstandardised regression coefficients (B), constant (intercept), the 






 change for each step of the 
regression model  
 
All ten social support variables were added as predictor variables in the regression. 
Mood (HADS Depression transformed scale) was added to explore if it was a significant 
predictor of diabetes specific quality of life. Addition of the following variables added 
no further prediction and were excluded from the final regression model using the 
methods outlined as per stepwise regression analysis: peers’ support for blood glucose 
monitoring, peers’ support for diet, family support for exercise and family support for 
blood glucose monitoring.  
 
The R coefficient for regression was significantly different from zero at the end of each 
step with the exception of step 1. For the final model, R
2
 was 0.537, F(7,72) = 11.91,     
p < .001. The adjusted R
2
 was 0.49 indicating that approximately 49% of the variability 
in PedsQL scores could be accounted for by levels of social support and mood. 
 
After step 1, with peer emotional and exercise support variables in the equation, R
2
 was 
0.04, F(2,77) = 1.612, p < .206. After step 2, with the square root of HADS-Depression 
added to the peer exercise and emotional support variables, R
2
 was 0.367,              
F(3,76) = 14.715, p < .001. Mood therefore accounted for an additional 32.7% of the 
variance in PedsQL (quality of life). After step 3, with family emotional support added 
to the equation, R
2
 was 0.422, F(4,75) = 13.680, p < .001 accounting for an additional 
5.4% of the variance in PedsQL scores. After the addition of the family support for 
insulin management variable (step 4), R
2
 was 0.482, F(5,74) = 13.763, p < .001 
accounting for an additional 6.0% in the variance of PedsQL scores. With the addition of 
peers’ support for insulin management in step 5, R
2





p < .001, this variable accounted for an additional 2.9% of the variance in quality of life. 
Finally, the addition of family support for diet accounted for a further 2.6% of variance, 
R
2
 was 0.537, F(7,72) = 11.91, p < .001. 
 
A number of significant predictors were identified, namely levels of support for exercise 
by peers (β = .264, p = 0.012), levels of peers’ support for insulin management (β = .25, 
p = 0.03), levels of family emotional support (β = 0.50, p < 0.001), levels of family 
support for diet (β = 0.257, p = 0.049) and finally mood (β = 0.51, p < 0.01).  
 
In order to obtain a final regression model which contained only significant predictors, 
the significant predictors identified in the final model (step 6) were re-analysed using 
backward removal method of multiple regression. The unstandardised regression 





for this model are shown in Table 16. 
 
Table 16:  
Forced Entry Multiple Regression of only significant predictors identified on Quality of Life (PedsQL) 
 
Variables entered Unstandardised 
B 










Constant 27.357 4.741  .534 .503 










Insulin Management 1.650 .592 .249**   









Diet .252 .089 .332**   
*p < .05, **p < .01, N = 81 
 
The R coefficient for the regression was significantly different from zero               
F(5,75) = 17.17, p < .001. R
2 
was .53. The adjusted R
2





50 % of the variability in PedsQL scores could be accounted for by levels of social 
support and mood. 
 
In the final model, the criterion variable (PedsQL scores) was most strongly predicted by 
mood (β = .568, p < .01), followed by family emotional support (β = -.483, p < .01), 
levels of support for diet given by family (β = .332, p < .01), peer support for insulin 
management (β = .249, p < .01) and finally support given by peers for exercise              
(β = -.203, p < .01).  
 
The size and direction of the relationships suggest that participants with increased mood, 
higher levels of emotional support from family, higher levels of support for diet given by 
family, lower levels of support for insulin management given by peers and finally higher 
levels of support for exercise given by peers will have better diabetes-related quality of 
life (lower PedsQL scores). 
 
Effect size calculations (Cohen’s f 
2
) revealed a very large effect size of 1.16 and power 
(1 - β) of 1.00, which indicates that the analysis was sufficiently powered. This effect 
size is larger than previous studies, which typically report Cohen’s f 
2
 values of 0.3 to 






4.1 Summary of results 
The present study examines the nature and impact of diabetes-specific social support for 
adolescents with type 1 diabetes in Tayside, Forth Valley and Fife. This aim was met. 
The findings suggest that peers and family were perceived to provide different forms of 
diabetes-specific social support. The source and nature of the support also had a 
significant impact on metabolic control and quality of life.  
 
This section summarises the results of the study, considers to what extent the aims were 
met and the hypotheses confirmed, and discusses implications, methodological issues 
and suggestions for future research. 
4.1.1 Hypothesis 1 
The first hypothesis was confirmed: family was perceived to provide more support for 
practical diabetes management tasks (insulin management, blood glucose monitoring 
and diet) than peers. The current study is the only one to compare the relative and 
specific forms of support provided by peers and family in terms of their impact on 
metabolic control and quality of life. It also supports the findings of previous research 
that examined the separate roles of family and peer support on adherence (La Greca et 
al., 1995; Shroff Pendley et al., 2002). 
Hypotheses 1a, 1b, 1c 
Further examination of the data revealed that the support given for each of the practical 
diabetes management tasks (insulin management, blood glucose monitoring and diet) 
was provided more frequently by family than by peers. Therefore hypotheses 1a, 1b and 





Each of the hypotheses confirmed the findings of previous research (La Greca et al., 
1995; Shroff Pendley et al., 2002). This is not surprising in that parents are often 
fundamentally involved in diabetes management from diagnosis. Alternative 
explanations for the present study’s findings have also been considered. Existing studies 
measured the frequency of support using the interview form of the DSSQ (La Greca et 
al., 1995; Shroff Pendley et al., 2002). The number and percentage of family and peers 
reported to provide ‘at least one supportive behaviour’ was compared. The authors of the 
DSSI acknowledge the possibility of over-representation of support using this method 
and called for further development of the measure. However, the DSSQ (questionnaire) 
used in the current study provides a more sensitive measure of the frequency of support, 
including and acknowledging support behaviours that were present but infrequent. 
Despite a significant alteration to the way in which support is measured, the current 
findings continue to support the work of La Greca et al., (1995) and confirm the 
different support roles played by family and peers. 
 
4.1.2 Hypothesis 2 
The second hypothesis was not confirmed: When the frequency of support for both 
emotions and exercise were combined to provide a measure of ‘companionship-related 
support’, there was no significant difference between the frequency of support given by 
family or peers. 
 
Previous studies have indicated that support for emotions and exercise are both aligned 
with companionship and belonging (Bearman & La Greca, 2002; La Greca & Bearman, 
2002). La Greca et al., (1995) identified that peers provide significantly more support 
for companionship tasks. However, the current study does not reflect these findings. 
Analysis of exercise and emotional support as separate and distinct behaviours provided 





It was hypothesised that peers would provide more emotional support than family. 
However, this hypothesis was not confirmed: family was found to provide more 
emotional support than peers. 
 
This is contrary to the existing comparative study by La Greca et al. (1995), however it 
supports the findings of La Greca & Thompson, (1998). The latter study compared the 
frequency of social support by family and peers from varied socioeconomic backgrounds 
(including the population used in La Greca and colleagues’ 1995 study). They reported 
that participants from lower-income backgrounds reported that emotional support was 
provided more frequently (although non-significantly) by family than by peers. This 
indicated a potential influence of socioeconomic factors on the provision of social 
support. Whilst socioeconomic variables such as family income were not collected in the 
present study, it is possible that these factors might provide an alternative explanation 
for the current study’s findings. 
Hypothesis 2b 
Peers were found to provide more support for exercise than family, confirming this 
hypothesis. The current study included items such as “how often do peers invite [you] to 
join in exercising with them?”. These items highlight the companionship aspect to 
exercise and therefore support the findings of La Greca et al. (1995). 
4.1.3 Hypothesis 3 
The third hypothesis was not confirmed. Only three forms of diabetes-specific social 
support were found to be significant predictors of metabolic control. The strongest 
predictor was found to be support for insulin management given by peers, followed by 
blood glucose monitoring given by peers, low mood and finally family support for 




the exception of peers support for insulin management. In this study, increased support 
for insulin management was associated with poorer metabolic control. Each of these 
predictors will now be discussed in turn. 
 
The impact of specific forms of social support has not yet been studied in relation to 
metabolic control. Peer support for insulin management was the only variable that was 
negatively associated with HbA1c. Increased peer support for insulin management led to 
poorer metabolic control. This does not support existing research, which identified that 
peer support for insulin management had little effect on adherence (Bearman & La 
Greca, 2002). It is important to consider alternative explanations for these findings. 
First, there are only two items in the DSSQ-Friends that identify peer support for insulin 
management. Psychometric analysis revealed weaker internal consistency for this scale 
than other social support behaviours. There are potential limitations therefore in the 
present study’s methodology. Second, peer support for blood glucose monitoring was 
associated with better metabolic control and therefore one must consider the factors that 
differentiate support for blood glucose monitoring from insulin management. Blood 
glucose monitoring is acknowledged as the most challenging aspect of diabetes 
management (Bui et al., 2005) and includes reacting to hypoglycaemia at an early stage. 
Adolescents might therefore appreciate additional support to prevent acute difficulties 
such as hypoglycaemia worsening and requiring medical attention. Dependent on the 
management regimen of the adolescent, they may not be required to administer insulin 
during the day when in the presence of peers. It is therefore less likely that they would 
require peer support. It is possible that support for insulin management may also be 
interpreted as a parental role, and thus would not be appreciated as ‘helpful’ by the 
adolescent if peers were to take on this responsibility. Whilst ‘perceived helpfulness’ of 
social support is not reported in the current study, future research should include the 
relative importance of perceived helpfulness of social support in relation to HbA1c and 






Bearman & La Greca (2002) reported that peer support for blood glucose monitoring 
significantly predicted adherence to blood glucose monitoring tasks. It is of note that in 
the current study, support for blood glucose monitoring was provided with relatively 
little frequency, but when this support was available from peers, it was a significant 
predictor of metabolic control. Peer support for blood glucose monitoring was a more 
significant predictor than any of the family factors. Whilst similar support provided by 
family was reported more frequently, it did not appear to predict metabolic control. 
Consequently it would be interesting to consider the nature of the support provided and 
how ‘supportive’ the adolescents rated the behaviours. For example, if support for blood 
glucose monitoring was interpreted as ‘nagging’ from the family, but ‘helpful’ from 
peers, this might provide more information to explain our findings. 
 
Previous research has indicated the importance of low mood as a confounding variable 
in diabetes research. Despite few participants scoring in the ‘possible depression’ range, 
and none scoring in the ‘probable depression’ range, sub-clinical levels of mood were 
significant predictors of metabolic control. This supports existing research (Cox & 
Gonder-Frederick, 1992; Hood et al., 2006; Lawrence et al., 2006), although the 
direction of causation remains unclear. 
 
The final significant predictor (and the only family factor found to be a significant 
predictor) of metabolic control was family support for exercise. La Greca & Bearman 
(2002) identified that family support for exercise was not related to adherence. This 
study highlights that whilst family support for exercise is not frequent, it is important for 
metabolic control when provided. It is unclear how exercise support from the family 
affects metabolic control, and these findings might indicate an indirect relationship that 




more support for exercise may hold greater value for general health, including weight, 
body mass index (BMI) and/or fitness. Although not examined in the current study, 
higher adolescent weight and BMI have been associated with poorer metabolic control 
(Pietilainen et al., 1995) and may therefore act as a mediating factor in the relationship. 
Beliefs about exercise and general health are formed within the family context prior to 
adolescence and peer influence (Field et al., 2001). Parents are influential role models 
for maintaining general health and fitness. This might reflect on the adolescents’ general 
perceptions about health and well-being, including the importance of adherence to 
diabetes management tasks. 
 
4.1.4 Hypothesis 4 
The final hypothesis was confirmed in part. Peers’ compassionate support was more 
strongly associated with quality of life than peers’ support for diabetes management 
tasks. In the present study, better quality of life was most strongly predicted by higher 
levels of mood, a greater frequency of family emotional support and a greater frequency 
of support for diet given by family, but also by a lower frequency of support by peers for 
insulin management and higher frequency of support for exercise given by peers,.  
 
Low mood has been indicated as a significant predictor of poor quality of life in 
previous studies that have controlled for physical health status and complications (Grey 
et al., 1998; Guttmann-Bauman et al., 1998; Jacobson et al., 1997). The current study 
supports these findings despite a small number of participants reporting depressive 
symptoms. Previous research indicates that sub-clinical levels of psychological distress 
appear to influence self care, although the precise nature of these effects remains unclear 





The frequency of family emotional support was a significant predictor of quality of life. 
This has not yet been studied and therefore there is no existing research with which to 
compare the present study’s findings. Whilst adolescents spend increasingly more time 
away from the family home, family support remains important for diabetes-related well-
being. The number and nature of peer relationships can change throughout adolescence 
(Hardy et al., 2002), and the family can be the only stable source of emotional support 
concerning diabetes. The requirements and difficulties associated with diabetes 
management may be more apparent to family members. Therefore, adolescents may 
choose to discuss their diabetes concerns with family, so as not to appear ‘different’ or 
‘needy’ to their social group. Emotional support for diabetes care may promote self–
efficacy and enhance psychosocial adjustment, thereby leading to greater quality of life. 
 
A higher frequency of family support for diet was associated with better quality of life. 
Whilst there is limited available research which has examined the role of support for diet 
in relation to quality of life for adolescents with type 1 diabetes, some research has been 
undertaken for adults with type 2 diabetes. Sato, Miyashita, Suzukamo & Kazuma 
(2004) suggested that the burden of adhering to diet restrictions had a significant impact 
on quality of life. It is possible that if family were to provide support such as ‘joining 
you in eating the same foods’ (DSSQ-Family; La Greca & Bearman, 2002) this might 
reduce the impact of ‘being different’, reduce the sense of isolation and normalise the 
dietary requirements of the individual with diabetes.  
 
Increased support for insulin management by peers was associated with poorer quality of 
life. Alternative explanations for the present study’s findings are described above when 
considering metabolic control. Future implications of this research include the need to 
identify how ‘helpful’ the young person perceived the support to be. If it were perceived 




might increase conflict, limit peer acceptance and integration, and therefore prevent 
successful transition to independence and autonomy.  
 
It was hypothesised that peer support for exercise would have a significant impact on 
quality of life and this was confirmed. Whilst there does not appear to be existing 
research with which to compare these findings, an explanation for the present study’s 
results is presented. Exercise is an important aspect of social integration, acceptance and 
‘normalisation’ for the adolescent. Support for exercise does not necessitate discussions 
about diabetes or diabetes care, therefore the young person is able to develop a sense of 
identity that is not focused on diabetes. The establishment of a sense of identity is vital 
to successful adolescent development and quality of life (Holmbeck, 2002).  
 
4.2 Limitations and suggestions for future research 
The limitations of the present study must be noted. First, despite achieving sufficient 
power in all statistical analyses, the number of participants was relatively small. 
Analysis of the final hypothesis revealed a larger effect size than would be predicted in 
general psychological research (Barker et al., 2002). Previous studies that have included 
an adolescent diabetes population typically report medium effect sizes (Bennett Johnson 
& Meltzer, 2002; La Greca et al., 1995). However, research that has included measures 
of social support and quality of life have consistently reported medium to large effect 
sizes (Lewandowski & Drotar, 2007; Skinner et al., 2000). It is plausible therefore that a 
greater variability within quality of life data might contribute to the increased effect size.  
 
The number of participants who failed to attend their appointment and were 
subsequently unable to consent to participate in the current study was similar to rates 
reported by Kaufman and colleagues (1999). Patients who do not attend their diabetes 




with their diabetes care (Kaufman et al., 1999). Information about patients who did not 
consent to participate was not available in the current study, but it is worth considering 
that an important cohort of patients may therefore be missing from the analysis. For 
those who did consent to participate, the drop-out rate was consistent with those reported 
in similar studies (Bearman & La Greca, 2002; Hains et al., 2007; La Greca et al., 
1995). 
 
Significantly more adolescents in the current study indicated that they used an insulin 
pump than national prevalence statistics suggest (Greene & Waugh, 2004). NHS Tayside 
is currently a leading UK centre for insulin pump therapy in young people with diabetes 
and therefore has access to additional funding for pump therapy. Unsurprisingly, the vast 
majority of pump users within the current study were patients within the Tayside clinics. 
Whilst previous research has indicated that pump use is associated with better quality of 
life, and better metabolic control (Battelino, 2006; McMahon et al., 2005), these 
differences were not observed in the current study. The reasons remain unclear and 
would require further investigation. 
 
The current study did not find any participants who scored within the ‘probable 
depression’ range using the HADS. Each clinic involved in the present study also had a 
Clinical Psychologist attached to the team, and therefore it is likely that patients 
exhibiting significant depressive symptoms may have been identified and offered 
treatment prior to the study commencing. It is possible that young people experiencing 
significant symptoms associated with depression would be less likely to attend their 
clinic appointment and therefore were not available to participate in the study.  
 
The average HbA1c of the current sample was significantly higher than the 




and international adolescent populations (Greene & Waugh, 2004; Scott et al., 2006). 
The reasons for this are unclear and would require further investigation. 
 
The current study used an average measure of metabolic control over the previous 12 
months. However the HADS depression subscale identified mood within the last four 
weeks. Any impact of recent mood changes on metabolic control might have been 
masked through the use of the average HbA1c. Future research might also include a 
measure of the most recent HbA1c when considering measures which identify mood 
states, e.g., anxiety or low mood. 
 
The measures used in the present study are not without some limitations. Although the 
DSSQ has many strengths, it is not ideal for adolescents using insulin pumps. A number 
of questions are less relevant to this population (e.g. “how often does your family/friends 
give you your injections?”). To date there are no available diabetes-specific social 
support measures developed to include pump use. As pumps become more widely used 
within diabetes clinics, it is clear that the development of such a measure would be 
important. Likewise, as dietary advice for diabetes changes with new research, 
traditional rigid meal plans are becoming less common for adolescents with diabetes. 
This should be reflected in future measures.  
 
Family members were encouraged to leave the adolescent to complete the measures 
independently to minimise the possibility of socially-desirable responding. The majority 
of participants were accompanied by their family and it was not possible to isolate the 
adolescent completely due to the nature of clinics. As a result it is possible that the 
participants were subject to pressure to respond in a biased manner. 
 
The current study did not include parent or peer reports of the adolescent’s social 




Adolescents are generally viewed as the ‘best’ informants for social support (La Greca 
& Lemanek, 1996) although previous studies have indicated high levels of agreement 
between parent and adolescent reports (Laffel et al., 2003). One study, however, 
indicated that parents often report their adolescent to have higher levels of distress and 
poorer health than the young person self-reports (Hesketh et al., 2004). Should parents 
experience greater concern over their adolescent’s health status, this might impact on the 
nature and frequency of support provided. Therefore future research should consider 
social support from multiple perspectives. 
4.3 Clinical relevance 
Diabetes teams are constantly searching for new ways to engage adolescents and 
improve their metabolic control. More recently, quality of life has become an important 
outcome of treatment and therefore the identification of factors that may impact on 
either metabolic control or quality of life is relevant to developing services. Low mood 
has consistently been found to impact on both metabolic control and quality of life, even 
at sub-clinical levels. Therefore a comprehensive assessment of the young person’s 
psychological status should be included in the adolescent’s routine care. This highlights 
the important role of Clinical Psychology within diabetes teams. There are potential 
training and supervision needs of the multidisciplinary team for understanding and 
working with psychological issues, and also the role of Clinical Psychology in treating 
more complex cases. 
 
Traditionally, the family of young people with diabetes was the main target of 
intervention, taking lead roles within clinic settings. There was a presumption that 
families were the sole source of influence over the young person and their diabetes care. 
This has shifted considerably, and now young people are often seen on their own in the 




support the continued involvement of families for adolescents, but also highlight the 
potential impact of peer support.  
 
Peers are often neglected in terms of their role in diabetes care for a number of reasons. 
The adolescents themselves may prefer to exclude peers from their diabetes care so as 
not to appear different and to protect their peer group integration. It is also possible that 
peers are not aware of the demands of a diabetes regime and therefore are unsure or 
unwilling to support the adolescent. It is clear that when peers do provide support for 
blood glucose monitoring, this has a significant effect on the adolescent’s metabolic 
control. One could suggest therefore, that diabetes teams provide peer education, and 
involve peers in the clinic process to increase knowledge and awareness. Greco and 
colleagues (2001) designed an intervention for peers focused on all aspects of diabetes 
care, including insulin management. Despite reporting an increase in knowledge and 
awareness of diabetes management tasks, this had little effect on adherence. The study 
was based on newly-diagnosed adolescents with diabetes who were still adjusting to 
their condition and focussed on all aspects of diabetes care including insulin 
management. The current study has found that increased support for insulin management 
by peers has a detrimental effect and therefore education programmes (such as that 
described by Greco et al., 2001) that attempt to increase this form of support may be 
unsuccessful. The present study suggests that a peer education programme focusing on 
blood glucose monitoring and reacting to hypoglycaemia may be more effective and 
helpful to adolescents with diabetes, even many years after diagnosis. 
 
It is important to acknowledge that peers have a distinct role from family, and that in 
line with adolescent development, diabetes care should aim to support the transition to 
independence for the adolescent rather than transfer dependence from family to peers. 
Peers have a clear role in terms of the development of identity and independence and 




care is unadvisable. It is important to ask the adolescent with diabetes about their 
experience of sources of helpful support, and use this information to collaborate with the 
young person thus supporting them to manage their diabetes as well as possible. 
4.4 Conclusion 
Family and peers provide important support for adolescents’ diabetes health and well-
being. The present study highlights the need to consider adolescents in both a social and 
family context when discussing influences on their diabetes care. 
 
The family has an important support role in many aspects of diabetes care. Therefore the 
family should not be forgotten within the context of the diabetes clinic, regardless of the 
patient’s age. This study has been the first to highlight the importance of family support 
for exercise and emotions. These have typically been understudied compared to support 
for practical diabetes management tasks, and yet are significantly associated with the 
adolescent’s metabolic control and quality of life.  
  
Peer support for blood glucose monitoring has a positive impact on metabolic control. 
However, similar support for insulin management appears to be detrimental. The 
mechanisms of these relationships therefore require further attention. It is suggested that 
peers provide support that facilitates normalisation and social integration. Peer support 
for exercise enables the adolescent to take part in ‘normal’ adolescent social activities, 
thereby allowing the young person to  develop a sense of identity separate from their 
diabetes. This also has a potential effect on an adolescent’s ability to define their identity 
as an independent, autonomous young person. Aspects of peer support were found to be 
stronger predictors of metabolic control than family support. This highlights the need to 
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